var data =
[
        {
            "Rank": "1 / 1",
            "Company": "Mylan (Headquarters)",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Robert J. Coury Global Center, 1000 Mylan Blvd., Canonsburg, Pennsylvania, 15317",
            "NumberOfProducts": "7500",
            "Headquarters": "Canonsburg, Pennsylvania",
            "Country": "United States",
            "Phone": "+1 724.514.1800",
            "OperationStatus": "Operating",
            "NumberOfLocations": "U.S. and Puerto Rico - 16 manufacturing, distribution, and administrative facilities\r\nOutside the U.S. and Puerto Rico -  39 production, distribution, and administrative facilities in 15 countries.  Mylan has 47 manufacturing facilities, 19 of which are located in India. \r\n",
            "EstimatedSales": "$11,433.9 million (2018)",
            "EstimatedEmployees": "35,000",
            "Founded": "1961"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "RD 156 Caguas West Industrial Park, Lot 24, Caguas, PR, 00725, USA",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Puerto Rico",
            "Phone": "+1 787-704-7500",
            "OperationStatus": "Operating",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "128",
            "Founded": "1986",
            "Land": "TBD",
            "PlantFacility ": "140,000 sq ft ",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "12720 Dairy Ashford Rd, Sugar Land, TX 77478",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "(281) 240-1000",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Bertek Pharmaceuticals Inc.",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "58",
            "Founded": "2003",
            "Land": "TBD",
            "PlantFacility ": " 42,692 sq ft",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "No",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "318 McCullough, San Antonio, TX 78215",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "(210) 476-8100",
            "OperationStatus": "Operating",
            "LocationAlias": "DPT Laboratories",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "105",
            "Founded": "1938",
            "Land": "TBD",
            "PlantFacility ": "258,000 sq ft",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "Yes",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "307 E JOSEPHINE ST SAN ANTONIO TX 78215",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "(210) 223-3281",
            "OperationStatus": "Operating",
            "LocationAlias": "DPT Laboratories",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "TBD",
            "Land": "TBD",
            "PlantFacility ": "115,048 sq ft",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "200 E JOSEPHINE ST SAN ANTONIO TX 78215",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "TBD",
            "OperationStatus": "Operating",
            "LocationAlias": "DPT Laboratories",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "TBD",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "1718 Northrock Ct, Rockford, IL 61103",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "815-282-1201",
            "OperationStatus": "Operating",
            "LocationAlias": "UDL Laboratories Inc, Mylan Institutional Inc",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "280",
            "Founded": "1980",
            "Land": "TBD",
            "PlantFacility ": "35,000 sq ft",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "49 NAPOLEON CT, SOMERSET, NJ, 08873-1392, USA",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "(732) 748-8882",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan API US LLC (Formerly Apicore US LLC)",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "40",
            "Founded": "2014",
            "Land": "TBD",
            "PlantFacility ": "10,160 sq ft",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "Yes",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "110 Lake St, St Albans City, VT 05478",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "(802) 527-7792",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Technologies Inc",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "250",
            "Founded": "1992",
            "Land": "TBD",
            "PlantFacility ": "390,000 sq ft.",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "781 Chestnut Ridge Road, Morgantown, WV 26505",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "United States",
            "Phone": "(304) 599-2595",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Pharmaceuticals",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "277",
            "Founded": "1961",
            "Land": "TBD",
            "PlantFacility ": "335,000 sq ft",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Damastown Industrial Park,\r\nMulhuddart, Dublin 15, Ireland",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Ireland",
            "Phone": "+ 353 1 8852700",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Damastown",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "TBD",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "25 Baldoyle Industrial Estate,\r\nGrange Road, Dublin 13, Ireland",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Ireland",
            "Phone": "+353 1 8281900",
            "OperationStatus": "Operating",
            "LocationAlias": "McDermott Laboratories Limited, t/a Mylan Dublin Respiratory",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "300",
            "Founded": "2015",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "35/36 Baldoyle Industrial Estate,\r\nGrange Road, Dublin 13, Ireland",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Ireland",
            "Phone": "+353 1 8398600",
            "OperationStatus": "Operating",
            "LocationAlias": "McDermott Laboratories Limited, t/a Mylan Dublin, t/a Gerard Laboratories",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "2014",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Kilroe East, Inverin, Co. Galway, Ireland",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Ireland",
            "Phone": "+353 91 505600",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Teoranta",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "TBD",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Route de Belleville\r\n01400 Châtillon-sur-Chalaronne, France",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "France",
            "Phone": "+334 74 45 54 42",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Laboratories SAS",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "351",
            "Founded": "2002",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Rue de Lartigue 33700 Mérignac, France",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "France",
            "Phone": "+33 5 56 55 35 35",
            "OperationStatus": "Operating",
            "LocationAlias": "Meda Manufacturing",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "250",
            "Founded": "1993",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "Betadine: 38 million units per year of the 45 million units of pharmaceutical specialties",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "360 avenue Henri schneider\r\n69330 Meyzieu, France",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "France",
            "Phone": "+334 37 44 31 10",
            "OperationStatus": "Operating",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "50",
            "Founded": "2002",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "Yes",
            "VolumeCapacityOverview": "TBD",
            "API": "NO",
            "Biosimilars / Biologicals": "No",
            "CMO / CMDO": "No",
            "Finished Dose Form (FDF) / Generic": "No"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Via Robbio 35\r\nConfienza, Pavia, 27030",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Italy",
            "Phone": " +39 0384 689111",
            "OperationStatus": "Operating",
            "LocationAlias": "Meda Pharma SpA",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "TBD",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Lütticherstr. 5 53842 Troisdorf,  Germany",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Germany",
            "Phone": "+ 49 2241 25249-0",
            "OperationStatus": "Operating",
            "LocationAlias": "Madaus GmbH / Meda",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "282",
            "Founded": "1975",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "ul. Daniszewska 10, 03 - 230 Warsaw",
            "NumberOfProducts": "TBD",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Poland",
            "Phone": "+ 48 22 814 43 99",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Pharmaceuticals Sp. z o.o.",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "195",
            "Founded": "2005",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "2900 Komárom, Mylan utca 1. Hungary",
            "NumberOfProducts": "No production",
            "Headquarters": "Hertfordshire, UK",
            "Country": "Hungary",
            "Phone": "+36-34696230",
            "OperationStatus": "Operating",
            "LocationAlias": "Mylan Hungary Kft.",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "521",
            "Founded": "2010",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "18,000 m2",
            "VolumeCapacityOverview": "TBD",
            "API": "NO",
            "Biosimilars / Biologicals": "NO",
            "CMO / CMDO": "NO",
            "Finished Dose Form (FDF) / Generic": "NO"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "F – 4& F – 12, Malegaon MIDC,\r\nSinnar, Nashik – 422113",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 2551 – 304777 / 230092 / 93",
            "OperationStatus": "Operating",
            "LocationAlias": "FDF – 1 (Sinnar)",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(FDF-2) H-12 & H-13, MIDC, Waluj, Aurangabad, Maharashtra State, 431136, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "022 – 33021000 / 022 – 33021000",
            "OperationStatus": "Operating",
            "LocationAlias": "FDF – 2 ( Aurangabad)",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(FDF-3) Plot No. 11, 12 &13, Indore Special Economic Zone Pharma Zone, Phase II, Sector III Pithampur, District - Dhar, Madhya Pradesh, 454775, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "07292 – 307200",
            "OperationStatus": "Operating",
            "LocationAlias": "FDF – 3 ( Indore)",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Sy. No. S 16 & S 17 Green Industrial Park, Polepally Village, Jadcherla Mandal, Dist. – Mehboobnagar, Telangan – 509202",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "08542 – 307000 / 304658",
            "OperationStatus": "Operating",
            "LocationAlias": "FDF – 4 (Jadcherla)",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Survey No. 10, Gaddapotharam Village, Kazipally Indl. Area, Jinnaram Mandal, Medak – 50231",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 40 – 3049 1373, 8458 – 277248",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit-1 ( API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Survey No. 10 & 42, Gaddapotharam Village, Kazipally Indl. Area, Jinnaram Mandal, Medak – 502319",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 40 – 3049 3333",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit – 2 Astrix (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(Unit-3), Plot Nos. 35, 36, 38 to 40, 49 to 51, Phase IV IDA, Jeedimetla, Hyderabad, Telangana, 500055, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 40 – 30493800 / 23097777",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit – 3 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "16/B/1&2, S.V. Co-op, Industrial Estate, Phase 1, IDA Jeedimetla,\r\nHyderabad – 500055",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 40 – 23095576",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit – 5 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(Unit-7), Plot No. 14, 99 & 100, IDA, Pashamylaram Phase-II Patencheru, Sangareddy District,, Hyderabad, Telangana, 502307, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 40 – 30497901 / 8455 – 226962 / 226020",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit -7 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(Unit-8), G Chodavaram, Poosapatirega Mandal, Vizianagaram District, Vizianagaram, Andhra Pradesh, 535204, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 8922 – 258001 / 02 / 03 / 07 / 08",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit -8 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(Unit-9), Plot No. 5, Road No. 12, J.N. Pharma City, Tadi Village Parawada Mandal,, Visakhapatnam, Andhra Pradesh, 531021, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 8924 – 236025",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit -9 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(Unit-10), Plot No. 86, Ramky Pharma City (India) Ltd, SEZ, JN Pharma City, Parawada Mandal, Visakhapatnam, Andhra Pradesh, 531019, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 8924 – 236185",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit -10 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(Unit-11), Plot No. 1-A/2, MIDC Industrial Estate Taloja, Panvel, District Raigad, Navi Mumbai, Maharashtra, 410208, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "+ 91 – 22 – 2740 2900",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit -11 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(Unit-12),Plot No.28, Survey No. 1,3,9&26(Part) J.N.Pharma City, Thanam Village, Parawada Mandal,, Visakhapatnam, Andhra Pradesh, 531021, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "0891 – 6699066",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit -12 (API Manufacturing)",
            "API": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Beta Lactam Division, 152/6 & 154/16, Doresanipalya, Bilekahalli, Bannerghatta Road, Bangalore, Karnataka, 560076, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "080 – 67397000",
            "OperationStatus": "Operating",
            "LocationAlias": "Agila Specialties Pvt. Ltd. / Complex1(Injectables)–BLD, SPD and Cepha",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "(OTL), Plot No. 284-B, Bommasandra Jigani Link Road, Industrial Area, Anekal Taluk, Bangalore, Karnataka, 560105, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "080 – 39254800",
            "OperationStatus": "Operating",
            "LocationAlias": "Complex 2 (Injectables)- OTL and SFF",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Plot No. 13 A& 14, SIPCOT Phase II, Krishnagiri Main Road, Hosur, Dist: Krishnagiri,Tamil Nadu – 63510",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "04344 – 661400",
            "OperationStatus": "Operating",
            "LocationAlias": "Agila Specialties Pvt. Ltd. / Hosur (Injectables)",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "P No. 28, Sy No.1, 3, 9 & 26,Jawaharlal Nehru Pharma City,Thanam Village, Parawada Mandal, Visakhapatnam – 531021",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "Phone": "0891 - 6699066",
            "OperationStatus": "Operating",
            "LocationAlias": "Injectables – 1"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Sy. No. 47 1A, 1B1, 1B2 & 48 Mukteswarapuram Village,Jaggaiahpet Mandal, Krishna District,Andhra Pradesh.",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Injectables – 2"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Sterile Product Division, Opp IIM, Bilekahalli, Bannerghatta Road, Bangalore, Karnataka, 560076, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Agila (A Mylan Company)",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "No: 19 A, Plot No: 284 B/1, Bommasandra-Jigani Link Road, Industrial Area, Anekal Taluk, Bangalore, Karnataka, 560105, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Specialty Formulation Facility",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Plot No. 1606 - 1609, G.I.D.C., Sarigam, Tal. - Umergam, Dist Valsad, Gujarat, 396155, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Sarigam",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "1 / 1",
            "Company": "Mylan ",
            "Ownership": "Public: NasdaqGS:MYL",
            "Website": "www.mylan.com",
            "Address": "Plot No. 20 & 21, Pharmez, Sarkhej Bavla National Highway No. 8 - A, Ahmedabad, Gujarat, 382213, IND",
            "Headquarters": "Hertfordshire, UK",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Ahmedabad",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "5 Basel Street, Petach Tikva, Israel, 49131",
            "NumberOfProducts": "North America: 500 generic prescription and OTC products in more than 2,000 dosage strengths and packaging sizes.\r\nEurope: Sells around 1000 products across a range of specialty medicines, generic medicines, API and OTC products.\r\nProduces approximately 300 APIs for its own use and for sale to third parties",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Israel",
            "Phone": "972-3-9267267",
            "OperationStatus": "Operating",
            "NumberOfLocations": "We own or lease 90 manufacturing and R&D facilities, occupying approximately 32.3 million square feet. As of December 31, 2018\r\nNorth America: 21 \r\nEurope: 31 \r\nInternational Markets: 38 \r\n",
            "EstimatedSales": "$ 18,854 million (2018)",
            "EstimatedEmployees": "42,535",
            "Founded": "1901",
            "Global HQ": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "5691 Main St., Stouffville, Ontario, L4A1H5, Canada",
            "NumberOfProducts": "Over 140 molecules",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Canada",
            "Phone": "416-291-8888",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Canada Limited",
            "EstimatedEmployees": "200",
            "PlantFacility ": "129,000 sq. ft",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "575 Hood Rd., Markham, Ontario, L3R4E1, Canada",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Canada",
            "Phone": "905-475-3370",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Canada Limited",
            "EstimatedEmployees": "250",
            "PlantFacility ": "67,000 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "1090 Horsham Road\r\nNorth Wales PA 19454",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "Phone": "888-838-2872",
            "OperationStatus": "Operating",
            "LocationAlias": "TEVA-USA"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "5000 Snyder Drive, Mexico, MO, 65265, USA",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Pharmaceuticals USA Inc",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "8-10 Gloria Lane, Fairfield, NJ, 07004-3306, USA",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Pharmaceuticals USA, Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Union Street, Road 195, Km 1.1, Fajardo, PR, 00738-1005, USA",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Puerto Rico LLC",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "2150 Perrowville Rd, Forest, VA 24551",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "Phone": "(434) 534-6300",
            "OperationStatus": "Shutting down by end of 2020",
            "LocationAlias": "Teva Pharmaceuticals",
            "EstimatedEmployees": "220"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "5040 Duramed Drive, Cincinnati, OH, 45213, USA",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Women's Health, Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "19 Hughes, Irvine, CA, 92618, USA",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Parenteral Medicines, Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "575 Chipeta Way, Salt Lake City, UT 84116",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "Phone": "(801) 401-7719",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "200 Elmora Ave, Elizabeth, NJ 07202",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "Phone": "(908) 527-9100",
            "OperationStatus": "Operating",
            "LocationAlias": "ACTAVIS ELIZABETH LLC",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "4955 Orange Dr, Davie, FL 33314",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "Phone": "(954) 585-1400",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis Laboratories FL, Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "13800 NW 2nd Pl # 190, Sunrise, FL 33325",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "Phone": "(954) 315-6600",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis - Sunrise"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "2945 W Corporate Lakes Blvd, Weston, FL 33331",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "Phone": "(954) 358-6100",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "577 Chipeta Way, Salt Lake City, UT, 84108",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis Laboratories UT, Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "13900 NW 2nd Street, Sunrise, FL, 33325",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "33 Ralph Avenue, Copiague, NY, 11726",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis Laboratories NY, Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Whiddon Valley, Whiddon Valley Industrial Estate, Barnstaple, Devon, EX32 8NS, GBR",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United Kingdom",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis UK Limited",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Ostravska 29/305, Opava-Komarov, , 74770, CZE",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Czech Republic",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Czech Industries s.r.o",
            "Founded": "1883 (Galena)",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Old Belfast Road, Millbrook, Larne, County, , Antrim, BT40 2SH, GBR",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United Kingdom",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva NI Limited",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Pallagi ut 13. H-4042 Debrecen, Hungary",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Hungary",
            "OperationStatus": "Operating",
            "LocationAlias": "Debrecen Site",
            "Founded": "1952 (Biogal)",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Vegyipari Park (Industrial Area), 024/180 hrsz, Sajobabony, H-3792 P.O. Box 6 Hungary",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Hungary",
            "OperationStatus": "Operating",
            "LocationAlias": "Sajobabony Site",
            "Founded": "2005",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Strada Statale Briantea km 36 n.83, 23892, Bulciago (LC) Italy",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Italy",
            "OperationStatus": "Operating",
            "LocationAlias": "Bulciago Site",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Via Enrico Fermi 520, 21042, Caronno Pertusella (VA), Itally",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Italy",
            "OperationStatus": "Operating",
            "LocationAlias": "Sicor srl (Caronno Pertusella Site)",
            "Founded": "1975 (I.C.F.I)",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Via Terrazzano 77 20017, Milano, Italy",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Italy",
            "OperationStatus": "Operating",
            "LocationAlias": "Sicor-Societa Italiana Corticosteroidi, SRL (Rho Site)",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Tenuta S. Alessandro sn - 13048 Santhia (VC), Italy",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Italy",
            "OperationStatus": "Operating",
            "LocationAlias": "Santhia Site",
            "Founded": "1983",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "S.S. 235 km 16,600 27019, Villanterio (PV), Italy",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Italy",
            "OperationStatus": "Operating",
            "LocationAlias": "Sicor srl (Villanterio Site)",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Plot No. Q1 to Q4 Industrial Area Ghirongi, Malanpur, Distt. Bhind (M.P.), 477117, IND",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "India",
            "Phone": "07539-283151, 07539-283153",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva API India Private Ltd. - Malanpur site",
            "Founded": "2008",
            "API": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Plot No. A-2, A-2/1, A-2/2 UPSIDC Industrial Area Bijnor Road, Gajraula, Amroha, 244235, India",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva API India Private Ltd. - Gajraula Site",
            "API": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Plot Nos. A-1, A-1/1 & A-1/2 UPSIDC Industrial Area Bijnor Road, Gajraula, Amroha, 244235, India",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva API India Private Ltd. - Gajraula Site",
            "Founded": "1994",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Plot No. 15, Additional Ambernath, Ambernath East, District Thane Maharshtra, Pin 421506, India",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "India",
            "Phone": "+91 22 66886700 / +91 22 66886775",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Watson Pharma Pvt Ltd",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Goa, IN, 403722",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Pharmaceuticals"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Via Luigi Pasteur 10, Nerviano, , 20014, ITA",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Italy",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis Italy Spa A Socio Unico",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Ulm, Germany",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Germany",
            "OperationStatus": "Operating",
            "LocationAlias": "ratiopharm"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Bulevard \"Bulgaria\", 1404 Manastirski Livadi, Sofia, Bulgaria",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Bulgaria",
            "Phone": "+359 2 489 9585",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Pharmaceuticals Bulgaria 109"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "3 Samokovsko Shose Str., Dupnitsa 2600",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Bulgaria",
            "Phone": "0701 58 477",
            "OperationStatus": "Operating",
            "LocationAlias": "Balkanpharma Dupnitsa AD"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "1 Krayrechna Str., Troyan 5600 Bulgaria",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Bulgaria",
            "Phone": "0670 68 102",
            "OperationStatus": "Operating",
            "LocationAlias": "Balkanforma Troyan AD"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Prudnicka cesta 98, 10291 Prigorge Brdovecko, Croatia",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Croatia",
            "OperationStatus": "Operating",
            "LocationAlias": "Pliva Hrvatska d.o.o - Savski Marof (SM) Site",
            "Founded": "1878",
            "API": "Yes"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Zagreb, Croatia",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Croatia",
            "OperationStatus": "Operating",
            "LocationAlias": "Pliva Hrvatska d.o.o - Savski Marof (SM) Site"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "ul. Mogilska 80 \r\n31-546 Kraków, Poland",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Poland",
            "Phone": "+48 12 617 80 00",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Operations Poland sp. z o.o."
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Vlajkova 199.\r\n16000 Leskovac, Serbia",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Serbia",
            "Phone": "+381 16 202 000",
            "OperationStatus": "Operating",
            "LocationAlias": "Actavis doo"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Waterford Industrial Park, Unit 301, Cork Rd, Waterford, X91 WK68, Ireland",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Ireland",
            "Phone": "+353 51 331 331",
            "OperationStatus": "Operating"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Swensweg 5, 2031 GA Haarlem, Netherlands",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Netherlands",
            "Phone": "+31 23 514 7147",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Nederland B.V"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Aston Ln N, Preston Brook, Runcorn WA7 3FA, United Kingdom",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "United Kingdom",
            "Phone": "+44 1928 707800",
            "OperationStatus": "Operating",
            "LocationAlias": "Teva Runcorn"
        },
        {
            "Rank": "3 / 2",
            "Company": "Teva Pharmaceutical Industries (including Allergan Gx)",
            "Ownership": "Public: NYSE:TEVA",
            "Website": "www.tevapharm.com",
            "Address": "Polígono Malpica calle C nº 4, Polígono Malpica calle F nº 91, 50016 Zaragoza, Spain",
            "Headquarters": "Petach Tikva, Israel",
            "Country": "Spain",
            "Phone": "+34 976 57 17 84",
            "OperationStatus": "Operating",
            "LocationAlias": "TEVA PHARMA S.L.U."
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Lichtstrasse 35, 4056 Basel, Switzerland",
            "NumberOfProducts": "Novartis: Global pharmaceuticals portfolio includes more than 50 key marketed products across various therapeutic areas.\r\nSandoz: generic pharmaceuticals and biosimilars - biosimilars, with a total of eight approved and marketed products. Sandoz markets approximately 1,000 molecules in countries around the world",
            "Headquarters": "Basel, Switzerland",
            "Country": "Switzerland",
            "Phone": "+41 61 324 11 11",
            "OperationStatus": "Operating",
            "LocationAlias": "Basel St. Johann (BS)",
            "NumberOfLocations": "64 manufacturing sites in 26 countries, organized into seven technology platforms\r\nSandoz Biologics, including biosimilars -10 sites on three continents including Kundl and Schaftenau in Austria, and Mengeš in Slovenia",
            "RegionalEntity": "Sandoz",
            "EstimatedSales": "$51,900 million \r\nSandoz Division $9,859 million (2018)",
            "EstimatedEmployees": "125,161",
            "Founded": "1996",
            "PlantFacility ": "724000 sq ft",
            "API": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Schaffhauserstrasse 101, 4332 Stein, Switzerland",
            "NumberOfProducts": "Sterile and solid dosage form medicines",
            "Headquarters": "Basel, Switzerland",
            "Country": "Switzerland",
            "Phone": "+41 62 868 61 11",
            "OperationStatus": "Operating",
            "LocationAlias": "Novartis Pharma Stein AG",
            "PlantFacility ": "64,700 sq ft",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Rothausstrasse 61, 4133 Schweizerhalle, Switzerland",
            "Headquarters": "Basel, Switzerland",
            "Country": "Switzerland",
            "Phone": "+41 61 823 14 46",
            "OperationStatus": "Operating",
            "LocationAlias": "Novartis Pharma Schweizerhalle AG, Schweizerhalle (BL)",
            "PlantFacility ": "31700 sq ft",
            "API": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Biochemiestrasse 10\r\nA-6336 Langkampfen / Schaftenau\r\nAustria",
            "Headquarters": "Basel, Switzerland",
            "Country": "Austria",
            "Phone": "+43 5372 6996 0",
            "OperationStatus": "Operating",
            "LocationAlias": "BioInject, Sandoz, Feuerwehr Sandoz Schaftenau, Schaftsau plant",
            "VolumeCapacityOverview": "Prefilled syringes. Facility has the capacity to fill 18,000 syringes per hour and package 100 per minute.",
            "Biosimilars / Biologicals": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Biochemiestrasse 10, Kundl, Tyrol, A-6250, Austria",
            "Headquarters": "Basel, Switzerland",
            "Country": "Austria",
            "Phone": "+43-5338-200-0",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz GmbH",
            "API": "Yes",
            "Biosimilars / Biologicals": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Mondseestrasse 11\r\nA-4866 Unterach am Attersee\r\nAustria",
            "Headquarters": "Basel, Switzerland",
            "Country": "Austria",
            "Phone": "+43 7665 8123 0",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, EBEWE Pharma Ges.m.b.H Nfg. KG",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Puurs, Belgium",
            "Headquarters": "Basel, Switzerland",
            "Country": "Belgium",
            "OperationStatus": "Operating"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "145 Jules-Leger Street, Boucherville, QC, J4B 7K8, Canada",
            "Headquarters": "Basel, Switzerland",
            "Country": "Canada",
            "OperationStatus": "Divested to Avar Pharmaceutical Service in 2018",
            "LocationAlias": "Sandoz Canada Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "8 Rue de l'Industrie, 68330 Huningue, France",
            "NumberOfProducts": "Biomedicines",
            "Headquarters": "Basel, Switzerland",
            "Country": "France",
            "Phone": "+33 3 89 89 51 31",
            "OperationStatus": "Operating",
            "EstimatedEmployees": "500",
            "PlantFacility ": "35000 sq ft"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Otto-von-Guericke-Allee 1, 39179 Barleben, Germany",
            "Headquarters": "Basel, Switzerland",
            "Country": "Germany",
            "Phone": "+49 39203 710",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Salutas Pharma GmbH",
            "PlantFacility ": "340,000 sq ft",
            "VolumeCapacityOverview": "Eight billion tablets and distribute 200 million pharmaceutical packs",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Keltenring 9, 82041 Oberhaching, Germany",
            "Headquarters": "Basel, Switzerland",
            "Country": "Germany",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz GmbH, Hexal AG",
            "Biosimilars / Biologicals": "Yes",
            "Labs / R&D / Technology Center": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Lange Göhren 3, 39171 Sülzetal, (Osterweddingen) Germany",
            "Headquarters": "Basel, Switzerland",
            "Country": "Germany",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Salutas Pharma GmbH"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Industriestrasse 25 83607 Holzkirchen Germany",
            "Headquarters": "Basel, Switzerland",
            "Country": "Germany",
            "Phone": "+49 8024 476 0",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz",
            "PlantFacility ": "64200 sq ft",
            "VolumeCapacityOverview": "43 million active ingredient plasters here every year",
            "API": "Yes",
            "# of products": "400 active ingredients"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Francois-Mitterrand-Allee 1, Rudolstadt, , D-07407, Germany",
            "Headquarters": "Basel, Switzerland",
            "Country": "Germany",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Aeropharm",
            "PlantFacility ": "44000 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Emil von Behring Strasse 76\r\nD-35041 Marburg, Germany",
            "Headquarters": "Basel, Switzerland",
            "Country": "Germany",
            "OperationStatus": "Operating",
            "LocationAlias": "Novartis Manufacturing GmbH",
            "EstimatedEmployees": "240",
            "Founded": "2015",
            "Biosimilars / Biologicals": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Öflinger Str. 44, 79664 Wehr, Germany",
            "NumberOfProducts": "Tablets",
            "Headquarters": "Basel, Switzerland",
            "Country": "Germany",
            "Phone": "+49 7762 820",
            "OperationStatus": "Operating",
            "LocationAlias": "Novartis Pharma Produktions GmbH",
            "PlantFacility ": "31,700 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Raheens East, Ringaskiddy, Co. Cork, Ireland",
            "Headquarters": "Basel, Switzerland",
            "Country": "Ireland",
            "Phone": "+353 21 486 2000",
            "OperationStatus": "Production building looks set for closure prior to mid-2022. ",
            "LocationAlias": "Ringaskiddy",
            "EstimatedEmployees": "Anticipated production outsourced, layoff of 320 / 600 employees",
            "PlantFacility ": "85,000 sq ft",
            "API": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Plot No. 8-A/2 and 8-B TTC Industrial Area Kalwe Block, Villiage Dighe, Navi Mumbai, Maharashtra, 400708, IND",
            "Headquarters": "Basel, Switzerland",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz Private Limited",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Plot Nos. D-31 & D-32 MIDC TTC Industrial Area Turbhe, Thane Belapur Road, Navi Mumbai, Mahatashtra, 400705, IND",
            "Headquarters": "Basel, Switzerland",
            "Country": "India",
            "OperationStatus": "Exited site in Dec. 2018",
            "LocationAlias": "Sandoz Private Limited",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Plot No. L-1, Additional Phase MIDC, Mahad, Mahad Raigad, Maharashtra, 402301, IND",
            "Headquarters": "Basel, Switzerland",
            "Country": "India",
            "OperationStatus": "Divested to Olon S.pA in 2019",
            "LocationAlias": "Sandoz Private Limited",
            "EstimatedEmployees": "270",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Corso Verona, 165, Rovereto, Trentino, 38068, Italy",
            "Headquarters": "Basel, Switzerland",
            "Country": "Italy",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz Industrial Products S.p.A",
            "API": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Via Provinciale Schito, 131, 80058 Torre Annunziata NA, Italy",
            "NumberOfProducts": "heart failure drug Entresto (sacubitril+valsartan)",
            "Headquarters": "Basel, Switzerland",
            "Country": "Italy",
            "Phone": "+39 081 535 4111",
            "OperationStatus": "Operating",
            "LocationAlias": "Novartis",
            "PlantFacility ": "40100 sq ft"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Podlipie 16, 95-010 Stryków, Poland",
            "Headquarters": "Basel, Switzerland",
            "Country": "Poland",
            "Phone": "+48 42 710 61 00",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Lek SA",
            "PlantFacility ": "45000 sq ft"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "7A Livezeni Street, Targu Mures, , 540472, ROU",
            "Headquarters": "Basel, Switzerland",
            "Country": "Romania",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz S.R.L",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Verovskova Ulica 57, Ljubljana, -, 1526, Slovenia",
            "Headquarters": "Basel, Switzerland",
            "Country": "Slovenia",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Lek Pharmaceuticals d.d., Lek d.d.",
            "PlantFacility ": "83,000 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "2D Trimlini, Lendava, -, 9220, Slovenia",
            "Headquarters": "Basel, Switzerland",
            "Country": "Slovenia",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Lek Pharmaceuticals d.d., Lek d.d.",
            "API": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "27 Kolodvorska cesta, Menges, -, 1234, Slovenia",
            "Headquarters": "Basel, Switzerland",
            "Country": "Slovenia",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Lek Pharmaceuticals d.d., Lek d.d.",
            "PlantFacility ": "62400 sq ft",
            "API": "Yes",
            "Biosimilars / Biologicals": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "47 Perzonali, Prevalje, -, 2391",
            "Headquarters": "Basel, Switzerland",
            "Country": "Slovenia",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Lek Pharmaceuticals d.d., Lek d.d.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Ctra Granollers Cardedeu C251 KM.4, Les Franqueses Del Valles, Barcelona, 08520, ESP",
            "Headquarters": "Basel, Switzerland",
            "Country": "Spain",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz Industrial Products SA",
            "API": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "c/ Gorg del Moli d' En Puigverd, Palafolls, Barcelona, 08389, ESP",
            "Headquarters": "Basel, Switzerland",
            "Country": "Spain",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz Industrial Products SA",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Ronda de Santa Maria, 158, 08210 Barberà del Vallès, Barcelona, Spain",
            "NumberOfProducts": "Inhalation capsules to treat respiratory diseases",
            "Headquarters": "Basel, Switzerland",
            "Country": "Spain",
            "Phone": "+34 937 28 61 00",
            "OperationStatus": "Operating",
            "LocationAlias": "Novartis Farmaceutica",
            "PlantFacility ": "33000 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Kurtkoy, Turkey",
            "Headquarters": "Basel, Switzerland",
            "Country": "Turkey",
            "OperationStatus": "Operating",
            "LocationAlias": "Kurtkoy Manufacturing Facility",
            "PlantFacility ": "51700 sq ft"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "Pyewipe, Grimsby DN31 2SR, United Kingdom",
            "Headquarters": "Basel, Switzerland",
            "Country": "United Kingdom",
            "Phone": "+44 1472 355221",
            "OperationStatus": "Closing by end of 2020",
            "LocationAlias": "Novartis Grimsby Ltd.",
            "EstimatedEmployees": "400",
            "PlantFacility ": "64000 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "220 E Hanover Ave, Morris Plains, NJ 07950",
            "NumberOfProducts": "Cell and gene therapies / CAR-T immuno-oncology treatments",
            "Headquarters": "Basel, Switzerland",
            "Country": "United States",
            "Phone": "(973) 796-2900",
            "OperationStatus": "Operating",
            "LocationAlias": "Novartis",
            "PlantFacility ": "15600 sq ft",
            "Biosimilars / Biologicals": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "2555 W. Midway Blvd, Broomfield, CO, 80020, United States",
            "Headquarters": "Basel, Switzerland",
            "Country": "United States",
            "OperationStatus": "Commercial production closing during 2019",
            "LocationAlias": "Sandoz Inc",
            "API": "Yes"
        },
        {
            "Rank": "2 / 3",
            "Company": "Novartis (includes Sandoz)",
            "Ownership": "Public: SWX:NOVN",
            "Website": "www.novartis.com",
            "Address": "4700 Sandoz Dr, Wilson, NC, 27893, USA",
            "Headquarters": "Basel, Switzerland",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Sandoz, Eon Labs",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "235 East 42nd Street New York, NY, 10017",
            "NumberOfProducts": "Approximately 365 marketed products (prescription) and OTC in the US.\r\n100 projects in R&D.",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(212) 733-2323",
            "OperationStatus": "Operating",
            "NumberOfLocations": "58 Manufacturing Sites Worldwide Operated by PGS",
            "EstimatedSales": "$53, 647 Million (2018)",
            "EstimatedEmployees": "92,400",
            "Founded": "1849"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "L-8 (Part), L-9 & Gut No. 38 Midc Industrial Area, Waluj, Aurangabad, Maharashtra, 431136, IND",
            "Headquarters": "New York, NY",
            "Country": "India",
            "OperationStatus": "Operations ceased",
            "LocationAlias": "Hospira Healthcare India Private Limited",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Plot No. 116, 117,118,119, 111 (Part) and 123 (Part) Jawaharlal Nehru Pharma City (SEZ), Parawada (Mandal), Visakhapatnam, Andhra Pradesh, 531019, IND",
            "Headquarters": "New York, NY",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Hospira Healthcare India Private Limited",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "SIPCOT Industrial Park, B3, B4, B5 (part), B6 (part), B11-B18, B21-B23, B31-B33 Irungattukottai, Sriperumbudur, Kancheepuram District, Tamil Nadu, 602105, IND",
            "Headquarters": "New York, NY",
            "Country": "India",
            "OperationStatus": "Operations ceased",
            "LocationAlias": "Hospira Healthcare India Private Limited",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Plot No.3, Pharmez, Special Economic Zone, Ahmedabad, Gujarat, 382213, IND",
            "Headquarters": "New York, NY",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Zydus Hospira Oncology Private Limited (ZHOPL)",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Goa, India",
            "Headquarters": "New York, NY",
            "Country": "India",
            "OperationStatus": "Operating"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Via Fosse Ardeatine, 2, Liscate, 20060, Italy",
            "NumberOfProducts": "lyophilized fill-finish of sterile injectable products",
            "Headquarters": "New York, NY",
            "Country": "Italy",
            "Phone": "+39 02 954541",
            "OperationStatus": "Operating",
            "LocationAlias": "Hospira S.p.A., Avara Pharmaceutical Spa",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "KM 1.9 Road 689, Vega Baja, PR, 693, United States",
            "NumberOfProducts": "SOD: Solid Oral Dose",
            "Headquarters": "New York, NY",
            "Country": "Puerto Rico",
            "Phone": "+1 787-858-2323",
            "OperationStatus": "Operating",
            "LocationAlias": "Pfizer Pharmaceuticals LLC, Upjohn ",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "PR-2, Barceloneta 00652, Puerto Rico",
            "NumberOfProducts": "API: Active Pharmaceutical Ingredient\r\nSOD: Solid Oral Dose",
            "Headquarters": "New York, NY",
            "Country": "Puerto Rico",
            "Phone": "+1 787-846-4300",
            "OperationStatus": "Operating",
            "LocationAlias": "Upjohn"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Highway 301 North, Rocky Mount, NC, 27801",
            "NumberOfProducts": "Sterile injectables",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Hospira",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "1200 Parkdale Rd, Rochester, MI, 48307, United States",
            "NumberOfProducts": "Penicillin",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(248) 650-6400",
            "OperationStatus": "Operating",
            "LocationAlias": "King Pharmaceuticals, Pfizer Global Supply",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "7000 Portage Road,, Kalamazoo, MI, 49001, United States",
            "NumberOfProducts": "API and sterile injectables",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "OperationStatus": "Operating",
            "LocationAlias": "Pharmacia and Upjohn Company LLC, ",
            "PlantFacility ": "1,300 acre",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "1 Burtt Rd, Andover, MA 01810",
            "NumberOfProducts": "Biologicals and vaccines",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(978) 475-9214",
            "OperationStatus": "Operating",
            "LocationAlias": "Andover Clinical Manufacturing Facility (ACMF)",
            "PlantFacility ": "70-acre site\r\n",
            "Biosimilars / Biologicals": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "160 Industrial Dr, Franklin, OH 45005",
            "NumberOfProducts": "API: Active Pharmaceutical Ingredient",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(937) 746-3603",
            "OperationStatus": "Operating",
            "PlantFacility ": "48,000 sq ft",
            "VolumeCapacityOverview": "heparin active pharmaceutical ingredient (API)",
            "API": "Yes",
            "# of products": "Ships 140 million units of medicine of both sterile injectables and liquid/semi-solids",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "1776 Centennial Dr, McPherson, KS 67460",
            "NumberOfProducts": "Biologics, biosimilars and sterile injectables",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(620) 241-6200",
            "OperationStatus": "Operating",
            "EstimatedEmployees": "1,800",
            "Biosimilars / Biologicals": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "2232 N Pleasant View Rd, Middleton, WI 53562",
            "NumberOfProducts": "API: Active Pharmaceutical Ingredient",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(608) 836-3500",
            "OperationStatus": "Operating",
            "Founded": "1982",
            "PlantFacility ": "83,000 sq ft",
            "API": "Yes",
            "Biosimilars / Biologicals": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "401 N Middletown Rd, Pearl River, NY 10965",
            "NumberOfProducts": "19 products- including various vaccines, antibiotics, and oncology medicines, Biologics; clinical trial development products",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(845) 602-5000",
            "OperationStatus": "Operating",
            "Biosimilars / Biologicals": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "4285 N Wesleyan Blvd, Rocky Mount, NC 27804",
            "NumberOfProducts": "sterile injectable facility",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(252) 977-5111",
            "OperationStatus": "Operating",
            "PlantFacility ": "1.4 million sq ft",
            "VolumeCapacityOverview": "More than 400 million units"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Oak Park Rd, Sanford, NC 27330",
            "NumberOfProducts": "Vaccines intermediates and drug substance, and gene therapy drug substance and drug products",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(800) 879-3477",
            "OperationStatus": "Operating",
            "PlantFacility ": "230-acre"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "1945 Craig Rd, St. Louis, MO 63146",
            "NumberOfProducts": "Sterile injectable drug and device combination products",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "(443) 259-7800",
            "OperationStatus": "Operating",
            "LocationAlias": "Meridian Medical Technologies",
            "PlantFacility ": "300,000 sq ft",
            "VolumeCapacityOverview": "11 products, producing millions of units annually"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Wallingstown, Little Island Industrial Estate, Co. Cork, Ireland",
            "Headquarters": "New York, NY",
            "Country": "Ireland",
            "Phone": "+353 21 452 3600",
            "OperationStatus": "Operating",
            "LocationAlias": "Upjohn, Little Island Active Pharmaceutical Ingredient Plant",
            "API": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Ringaskiddy, Co. Cork Ireland",
            "Headquarters": "New York, NY",
            "Country": "Ireland",
            "Phone": "021 4378 701",
            "OperationStatus": "Operating",
            "LocationAlias": "Ringaskiddy Active Pharmaceutical Ingredient Plant",
            "API": "Yes"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Rijksweg 12, 2870 Puurs (Flanders), Belgium",
            "NumberOfProducts": "aseptic manufacturing- and packaging site (Vaccines Plant and the Syringe Plant )",
            "Headquarters": "New York, NY",
            "Country": "Belgium",
            "Phone": "+32 3 890 92 11",
            "OperationStatus": "Operating",
            "LocationAlias": "Pfizer Manufacturing Belgium"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Unnamed Road, Co. Dublin, Ireland",
            "NumberOfProducts": "Bioprocessing Operating Unit",
            "Headquarters": "New York, NY",
            "Country": "Ireland",
            "OperationStatus": "Operating",
            "LocationAlias": "Pfizer Grange Castle"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "Mooswaldallee 1, 79108 Freiburg im Breisgau, Germany",
            "Headquarters": "New York, NY",
            "Country": "Germany",
            "Phone": "+49 761 5180",
            "OperationStatus": "Operating",
            "LocationAlias": "Pfizer Manufacturing Deutschland GmbH"
        },
        {
            "Rank": "4 / 4",
            "Company": "Pfizer ",
            "Ownership": "Public: NYSE:PFE",
            "Website": "www.pfizer.com",
            "Address": "100 Route 206 North, Peapack, NJ 07977",
            "NumberOfProducts": "Validate manufacturing. This company has been described as a Marketer not Manufacturer",
            "Headquarters": "New York, NY",
            "Country": "United States",
            "Phone": "1.800.447.3360\r\n(973) 762-5761\r\n",
            "OperationStatus": "Operating",
            "LocationAlias": "Greenstone",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "1,200",
            "Founded": "1993",
            "Land": "130-acre",
            "PlantFacility ": "595,000 sq ft",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "No",
            "Biosimilars / Biologicals": "No",
            "CMO / CMDO": "No",
            "Finished Dose Form (FDF) / Generic": "No"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063 ",
            "NumberOfProducts": "Over 2,000 products marketed\r\nApproximately 300 APIs\r\nUS: 139 ANDAs and 3 NDAs awaiting approval",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 22) 4324 4324",
            "OperationStatus": "Operating",
            "NumberOfLocations": "44 manufacturing sites world wide",
            "RegionalEntity": "Biosintez\r\nTerapia\r\nOcular Technologies (branded ophthalmic portfolio)\r\nInSite Vision Inc (branded ophthalmic portfolio)\r\nGSK's Opiates business in Australia\r\nPharmalucence\r\nRanbaxy (generic drugs)\r\nURL Pharma (ANDAs and generic products )\r\nDUSA Pharmaceuticals (dermatological device used to treat actinic keratoses)\r\nMSD with a focus on emerging markets\r\nCaraco\r\nTaro (generics) - Publically Held NYSE:TARO (84% voting interest by Sun)\r\nForests Inwood\r\nChattem Chemicals (controlled substances with an API facility)\r\nAble Laboratories (controlled substance manufacturing assets)\r\nICN (Hungary) (controlled substance API and dosage form manufacturing plant)",
            "EstimatedSales": "₹264,895 million (2018)",
            "EstimatedEmployees": "32,000+ ",
            "Founded": "1983"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "3708 St. Elmo Avenue Chattanooga, TN  37409",
            "NumberOfProducts": "20 API's and Glycine, Technical Grade (nutraceutical)",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "(603) 891-2086, (603) 321-4258",
            "OperationStatus": "Operating",
            "LocationAlias": "Chattem Chemicals, Inc.",
            "NumberOfLocations": "Single",
            "EstimatedEmployees": "78",
            "Founded": "2008",
            "API": "Yes"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "1385 Livingston Ave, North Brunswick, NJ, 08902, USA",
            "NumberOfProducts": "Prescription and OTC drugs in solid dosage forms",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "(732) 514-4380",
            "OperationStatus": "Operating",
            "LocationAlias": "Ohm Laboratories Inc / Ranbaxy Pharmaceuticals",
            "EstimatedEmployees": "136",
            "Founded": "2004",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "14 Terminal Road, New Brunswick, NJ, 08901, USA",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "(732) 514-1072",
            "OperationStatus": "Operating",
            "LocationAlias": "Ohm Laboratories Inc / Ranbaxy Pharmaceuticals",
            "EstimatedEmployees": "100",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "270 Prospect Plains Road, Cranbury, NJ, 08512, USA",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "(609) 495-2800",
            "OperationStatus": "Operating",
            "LocationAlias": "Sun Pharmaceutical Industries Inc.",
            "EstimatedEmployees": "40",
            "Founded": "2004",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "29 Dunham Road, Billerica, MA 01821",
            "NumberOfProducts": "Non-cytotoxic human injectable pharmaceuticals",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "781-275-7120",
            "OperationStatus": "Operating",
            "LocationAlias": "Pharmalucence, Inc.,",
            "NumberOfLocations": "Single",
            "Founded": "1985",
            "PlantFacility ": "70,000 sq. ft."
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "Kabay János street 29, Tiszavasvári H-4440",
            "NumberOfProducts": "Manufacturing of 2,120 pharmaceutical products.   Vegetable based API's morphine, alkaloids, codein and its derivatives as well as Sennozide. Synthetic API. Chloroquine salts, pehnobarbital. Intermediate products and finished preparations (30 different types of preparations in solid dosage form, tables, film coated tablets and capsules)",
            "Headquarters": "Mumbai, India",
            "Country": "Hungary",
            "Phone": "+36 42 521 000",
            "OperationStatus": "Opearating",
            "LocationAlias": "ALKALOIDA Chemical Company Zrt,",
            "API": "Yes"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "Str. Fabricii, 124, Cluj-Napoca, Cluj, 400640, Cluj-Napoca 400124, Romania",
            "NumberOfProducts": "Manufacuring of generics",
            "Headquarters": "Mumbai, India",
            "Country": "Romania",
            "Phone": "+40 264 501 500",
            "OperationStatus": "Operating",
            "LocationAlias": "S.C. Terapia, Terapia Ranbaxy",
            "Founded": "1920"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "Druzhby str., 4, Penza, Russia, 440033",
            "NumberOfProducts": "180 names of drugs of various dosage forms: tablets, ointments, suppositories, powders for injections, infusion solutions, ampouled solutions for injections",
            "Headquarters": "Mumbai, India",
            "Country": "Russia",
            "Phone": "+7(8412)57-72-72, +7(8412)58-32-42, +7(8412)58-32-48, +7(8412)58-32-37",
            "OperationStatus": "Operating",
            "LocationAlias": "JSC “\"Biosintez”\"",
            "Founded": "1955"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "Address": "25 Upton Dr, Wilmington, MA 01887",
            "NumberOfProducts": "Levulan® (aminolevulinic acid HCl)\r\nphotodynamic therapy platform.",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "(978) 657-7500",
            "OperationStatus": "Operating",
            "LocationAlias": "DUSA Pharmaceuticals, Inc"
        },
        {
            "Rank": "6 / 5",
            "Company": "Sun Pharma",
            "Ownership": "Public: NSEI:SUNPHARMA",
            "Website": "www.sunpharma.com",
            "NumberOfProducts": "Pharmaceutical manufacturing, production and research laboratories,  administration, distribution, and warehousing",
            "Headquarters": "Mumbai, India",
            "Country": "Canada",
            "OperationStatus": "Operarating",
            "LocationAlias": "Taro Pharmaceuticals (publically held company, 84% shareholder is Sun Pharma)",
            "PlantFacility ": "159,000 sq. ft.",
            "Warehouse": "89,000 sq. ft."
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Else-Kröner-Str. 1 61352 Bad Homburg, Germany",
            "NumberOfProducts": "Fresenius Kabi has 322 approved active drugs. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products\r\nas well as the medical devices for administering these products",
            "Headquarters": "Homburg, Germany",
            "Country": "Germany",
            "Phone": "+49 6172 686 0",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Fresenius Kabi has 70​ production sites including compounding centers in Europe, North America, Latin America, Asia Pacific and Africa",
            "RegionalEntity": "Fresenius Kabi",
            "EstimatedSales": "€33,530 million (2018)",
            "EstimatedEmployees": "276,750",
            "Founded": "1996"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "D-35, Industrial Area, Kalyani, Nadia, West Bengal, 741235",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "Phone": " +91-3333255000",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi Oncology Limited",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "337",
            "Founded": "TBD",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "Yes",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Kishanpura, Baddi- 173205, Himachal Pradesh, India",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "Phone": "+91 11 2610 5570",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi Oncology Limited",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "TBD",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "Yes",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Plot No.1, Phase III, Honda Industrial Estate, Honda - Sattari, Goa - 403 530 India",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "Phone": "+91-832-6733600",
            "OperationStatus": "Operating",
            "LocationAlias": "Goa Plant"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Midc Warehouse,Shirur,\r\nPune, Maharashtra, 412220\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "Phone": "+91-2138232283",
            "OperationStatus": "Operating",
            "LocationAlias": "FRESENIUS KABI INDIA PRIVATE LIMITED",
            "Founded": "2015"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "D-10, Gautam Marg Nirman Nagar, Ajmer Road,\r\nJaipur, Rajasthan, 302006\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "Phone": "TBD",
            "LocationAlias": "FRESENIUS KABI INDIA PRIVATE LIMITED",
            "Founded": "2012"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "4Th Floor , 15-A, Mumbai, Pune Road\r\nPune, Maharashtra, 411003\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "LocationAlias": "Iveon Laboratories Ltd.",
            "Founded": "1998"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Sathy Road Ganapathy,\r\nCoimbatore, Tamil Nadu, 641006\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "LocationAlias": "FRESENIUS KABI INDIA PRIVATE LIMITED",
            "Founded": "2011"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "3Rd Floor, -20 , Mafatlal House, Backbay Reclamation\r\nMumbai, Maharashtra, 400020\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "LocationAlias": "FRESENIUS KABI INDIA PRIVATE LIMITED",
            "Founded": "2001"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Sco 41, 2Nd Floor, Sector 7C, Madhaya Marg\r\nChandigarh, Chandigarh,\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "171, Mahatma Gandhi Road , Thakurpukur\r\r\nKolkata, West Bengal, 700063\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "17-76-C-5 East Kalyanpuri , Uppal,\r\r\nHyderabad, Telangana, 500039\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "A-3 Midc, Ranjangaon\r\r\nPune, Maharashtra, 412210\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India",
            "Phone": "+91-2138-671600",
            "LocationAlias": "Ranjangaon Plant"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Lasudia Mori37 38 , Dewas Nakadewas Naka\r\r\nIndore, Madhya Pradesh, 458001\r\r\nIndia\r\r\n",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Vijay Warehousing, Gade Vasti , Wagholi\r\r\nSatara, Maharashtra, 412221\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "11 32M , Echelon Institutional\r\r\nGurgaon, Haryana, 120001\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "8/3, , Asaf Ali Road,\r\r\nNew Delhi, Delhi, 110002\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Plot No 11 , Echelon Institutional Area\r\r\nGurgaon, Haryana, 122001\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "#5-A, Gk Industrial Estate , 2Nd Street Alapakkam\r\r\nChennai, Tamil Nadu, 600040\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "N M R And Sons Complex, 96, Ground And First Floor , 5Th Main Chamarajpet\r\r\nBangalore, Karnataka, 560018\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "3Rd Floor Vagh Apartment , 3 Park Road\r\r\nMumbai, Maharashtra, 400057\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Phase-I, Plot No 136-138, Block-C Mangolpuri Industrial Area\r\r\nDelhi, Delhi, 110085\r\r\nIndia",
            "Headquarters": "Homburg, Germany",
            "Country": "India"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "3159 Staley Rd. Grand Island, New York, 14072-2028",
            "Headquarters": "Homburg, Germany",
            "Country": "United States",
            "Phone": " +1-716-773-0053",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi USA, LLC",
            "EstimatedEmployees": "900",
            "Land": " 65,143\r\n32,659 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "2020 N Ruby St. Melrose Park, Illinois, 60160-1112",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "United States",
            "Phone": " +1-708-450-7500",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi USA, LLC",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "800",
            "Founded": "2008",
            "Land": "124,267ft²",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "5200 Corporate Pkwy\r\nWilson, NC 27893",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "United States",
            "Phone": " +1-708-345-6170",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi USA, LLC",
            "EstimatedEmployees": "200",
            "Land": "57658 sq ft",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Lagedo Industrial Zone - 3465-157 Santiago de Besteiros",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "Portugal",
            "Phone": "+ 351 232 831 100 ",
            "LocationAlias": "Labesfal S.A",
            "Land": "90,000 sq mtrs"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Rapsgatan 7, 751 74 Uppsala, Sweden",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "Sweden",
            "Phone": "018-64 40 00",
            "EstimatedEmployees": "800",
            "Founded": "1998",
            "CMO / CMDO": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Kraftvägen 1, 196 37 Kungsängen, Brunna, Sweden",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "Sweden",
            "Phone": "08-581 780 00",
            "EstimatedEmployees": "200",
            "Founded": "1980",
            "API": "Yes",
            "CMO / CMDO": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Rapsgatan 7, 751 74 Uppsala, Sweden",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "Sweden",
            "CMO / CMDO": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Hafnerstraße 36, 8055 Graz, Austria",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "Austria",
            "Phone": "+43 (0)316 249 0",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi Austria GmbH",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "970+",
            "Founded": "1977",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Estermannstraße 17\r\n4020 Linz, Austria",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "Austria",
            "Phone": "+43 (0)732 7651 0",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi Austria GmbH",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "TBD",
            "Founded": "1947",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "Yes",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "TBD"
        },
        {
            "Rank": "7 / 6",
            "Company": "Fresenius ",
            "Ownership": "Public: FSNUF (OTCMKTS) ",
            "Website": "www.fresenius-kabi.com",
            "Address": "Freseniusstr. 1, 61169 Friedberg, Germany",
            "NumberOfProducts": "TBD",
            "Headquarters": "Homburg, Germany",
            "Country": "Germany",
            "Phone": "+49 (0) 6172 686-0",
            "OperationStatus": "Operating",
            "LocationAlias": "Fresenius Kabi Deutschland GmbH / Werk Friedberg",
            "EstimatedSales": "TBD",
            "EstimatedEmployees": "800",
            "Founded": "1997",
            "Land": "TBD",
            "PlantFacility ": "TBD",
            "LaboratoryR&D": "TBD",
            "Warehouse": "TBD",
            "Other": "TBD",
            "VolumeCapacityOverview": "TBD",
            "API": "TBD",
            "Biosimilars / Biologicals": "TBD",
            "CMO / CMDO": "TBD",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "10 / 7",
            "Company": "Aurobindo",
            "Ownership": "Public: BSE:524804",
            "Website": "www.aurobindo.com",
            "Address": "Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038 Telangana, India",
            "NumberOfProducts": "US portfolio - 569 ANDAs filed; 389 with final approval, 27 Tentative approval, and 153 under review",
            "Headquarters": "Telangana, India",
            "Country": "India",
            "Phone": "+91 (40) 6672 1200",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Overview: 29 manufacturing and packaging facilities\r\n15  formulation manufacturing facilities located in India, USA, Portugal and Brazil\r\n11 units for APIs / intermediates and 15 units (10 in India, 3 in USA, 1 in Brazil and 1 in Portugal) for formulations",
            "RegionalEntity": "AuroSource® is the Custom Research and Manufacturing division",
            "EstimatedSales": "$2758.55 million (2019)",
            "EstimatedEmployees": "22,000+",
            "Founded": "1986"
        },
        {
            "Rank": "12 / 8",
            "Company": "Lupin Limited",
            "Ownership": "Public: BSE:500257",
            "Website": "www.lupin.com",
            "Address": "3rd Floor, Kalpataru Inspire,\r\nOff. Western Expressway Highway, Santacruz (East),\r\nMumbai 400 055, India",
            "NumberOfProducts": "Has 75 FDA approvals for generics. ",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 22 6640 2323",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Eighteen (18) manufacturing facilities are spread across India, Japan, USA, Mexico and Brazil\r\nFive (5) 5 operational manufacturing sites dedicated to API production",
            "EstimatedSales": "$2.34 billion (2019)",
            "EstimatedEmployees": "20,000+",
            "Founded": "1968"
        },
        {
            "Rank": "14 / 9",
            "Company": "Hikma",
            "Ownership": "Public: LSE:HIK",
            "Website": "www.hikma.com",
            "Address": "1 New Burlington Place, Mayfair, London W1S 2HR",
            "NumberOfProducts": "Portfolio of 650+ products",
            "Headquarters": "London, UK",
            "Country": "United Kingdom",
            "Phone": "+44 (0) 20 7399 2760",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Locations in over 50 countries with 29 manufacturing plants and 7 R&D centers",
            "EstimatedSales": "$2,070 million (2018)",
            "EstimatedEmployees": "8,400",
            "Founded": "1978"
        },
        {
            "Rank": "15 / 10",
            "Company": "Dr. Reddy's",
            "Ownership": "Pubilc: BSE:500124 and NYSE: RDY",
            "Website": "www.drreddys.com",
            "Address": "8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India",
            "NumberOfProducts": "In the US:\r\nPrescription products: More than 80+ SKUs are marketed in over 350 dosing presentations\r\n• OTC: More than 170+ SKUs for private labels\r\npackaging presentations\r\n\r\nGlobal: over 200 generic versions of products\r\n\r\nThe company made 20 new ANDA filings in 2019 with the U.S. FDA. \r\nAs of March 31, 2019 cumulative filings were 279 in the United States\r\nAs of March 31, 2019, Dr. Reddy's had 110 filings pending approval with the U.S. FDA (107 ANDAs and 3 NDAs including 16 tentative approvals). Of the 107 ANDAs which are pending approval, 60 are Paragraph IV filings\r\n",
            "Headquarters": "Telangana, India",
            "Country": "India",
            "Phone": "+91-40-49002900",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Global generics segment has eleven manufacturing facilities within it. Ten of these facilities are located in India and one in the United States (Shreveport, Louisiana). In addition, there is one packaging facility in the United Kingdom",
            "RegionalEntity": "Dr. Reddy’s Laboratories, Inc. (Princton, NJ)",
            "EstimatedSales": "$2,169 million (2019)",
            "EstimatedEmployees": "21,966",
            "Founded": "1984"
        },
        {
            "Rank": "11 / 11",
            "Company": "Cipla",
            "Ownership": "Public: NSEI:CIPLA",
            "Website": "www.cipla.com",
            "Address": "Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013",
            "NumberOfProducts": "Offers over 1500 products in 65 therapeutic categories available in over 50 dosage forms\r\nAs on 31st Mar, 2019, Cipla had a total of 253 ANDAs of which 164 are approved, 24 are tentatively approved and 65 are under-approval. ",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 22 24826000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "46 state-of-the-art facilities including API and Formulations, manufacturing ",
            "EstimatedSales": "$2.3 billion \r\n(2019)",
            "EstimatedEmployees": "26,000+",
            "Founded": "1935"
        },
        {
            "Rank": "17 / 12",
            "Company": "Sawai Pharmaceutical",
            "Ownership": "Public: TSE:4555",
            "Website": "www.sawai.co.jp",
            "Address": "5-2-30 Miyahara Yodogawa-Ku Osaka, 532-0003 Japan",
            "NumberOfProducts": "Around 700 ethical pharmaceuticals, such as cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs",
            "Headquarters": "Osaka, Japan",
            "Country": "Japan",
            "Phone": "81-6-6105-5711",
            "OperationStatus": "Operating",
            "NumberOfLocations": "7 Factories (Japan) Kashima Factory, Kanto Factory, Osaka Factory, Sanda Factory, Sanda Nishi Factory, Kyushu Factory, Daini Kyushu Factory",
            "RegionalEntity": "Consolidated subsidiaries\r\nUpsher-Smith Laboratories, LLC\r\nMedisa Shinyaku Inc.\r\nKaken Shoyaku Co., Ltd.",
            "EstimatedSales": "JPY 184,341,000,000 (2018)",
            "EstimatedEmployees": "3,131",
            "Founded": "1929"
        },
        {
            "Rank": "16 / 13",
            "Company": "Sanofi",
            "Ownership": "Public: SNY (NYSE)\r\nEURONEXT: SAN",
            "Website": "www.sanofi.com",
            "Address": "54, Rue La Boétie, 75008 Paris, France",
            "NumberOfProducts": "Vaccines: 441 million containers (syringes, vials and lyophilized products) filled, including outsourced production\r\nPharmaceuticals: 4,700 million units",
            "Headquarters": "Paris, France",
            "Country": "France",
            "Phone": "+ 33 1 53 77 43 03",
            "OperationStatus": "Operating",
            "LocationAlias": "Winthrop US (generic drugs)",
            "NumberOfLocations": "Industrial production at 75 sites in 33 countries:\r\n◆ 8 sites for our Biologics operations;\r\n◆ 9 sites for our Injectables operations;\r\n◆ 33 sites for our Pharmaceuticals operations;\r\n◆ 14 sites for our Consumer Healthcare operations;\r\n◆ 11 sites for the industrial operations of Sanofi Pasteur in vaccines",
            "RegionalEntity": "Sanofi is the holding company of a consolidated group consisting of over 300 companies.  Significant subsidiaries\r\nAventis Pharma SA\r\nGenzyme Corporation\t \r\nHoechst GmbH \r\nSanofi-Aventis Deutschland GmbH\t \r\nSanofi-Aventis US LLC\t \r\nSanofi-Aventis Participations SAS \r\nSanofi Pasteur SA\t \r\nSanofi Pasteur Inc.\r\nSanofi Winthrop Industrie\r\nChattem, Inc.\r\n ",
            "EstimatedSales": "€ 34,463 million (2018)",
            "EstimatedEmployees": "104,226\t ",
            "Founded": "1973"
        },
        {
            "Rank": "8 / 14",
            "Company": "Stada",
            "Ownership": "DB:SAZ",
            "Website": "www.stada.com",
            "Address": "Stadastraße 2-18 61118 Bad Vilbel, Germany",
            "NumberOfProducts": "Currently, STADA has two biosimilars on the market: SILAPO®, an Erythropoietin biosimilar, and Grastofil®In financial year 2018, the number of Marketing Authorization Applications (MAAs) totaled over 750 and the number of Marketing Authorizations (MAs) amounted to more than 700\r\n",
            "Headquarters": "Bad Vilbel, Germany",
            "Country": "Germany",
            "Phone": "+49 06101 603-0",
            "OperationStatus": "Operating",
            "LocationAlias": "STADA Arzneimittel AG",
            "NumberOfLocations": "To be determined. Some locations include Bad Vilbel, Germany, Nizhny Novgorod, Russia, Huddersfield, United Kingdom and Vrsac, Serbia\r\n2017 Stada Media Document Stada Produktion\r\n- Bad Vilbel (Deutschland)*\r\n- Pfaffenhofen (Deutschland)*\r\n- Huddersfield (Großbritannien)*\r\n- Vršac (Serbien)*\r\n- Šabac (Serbien)*\r\n- Dubovac (Serbien)\r\n- Banja Luka (Bosnien-Herzegovina)*\r\n- Podgorica (Montenegro)*\r\n- Nizhny Novgorod (Russland)*\r\n- Obninsk (Russland)*\r\n- Ho-Chi-Minh City, Hoc Mon District (Vietnam)\r\n- Ho-Chi-Minh City, Binh Duong Branch (Vietnam 50% JV)*\r\n- Tuy-Hoa (Vietnam)*\r\n- Peking (China)\r\n- Buenos Aires (Argentinien)",
            "RegionalEntity": "STADApharm (generics)\r\nOthers",
            "EstimatedSales": "EUR 2,330.8 million (2018)",
            "EstimatedEmployees": "10,416",
            "Founded": "1895"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public: AMRX (NYSE)",
            "Website": "www.amneal.com",
            "Address": "400 Crossing Boulevard, Bridgewater, NJ 08807",
            "NumberOfProducts": "Generics segment includes over 200 product families and 124 products either approved but not yet launched \r\n",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(908) 947-3120",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Thirteen (13) manufacturing locations worldwide",
            "RegionalEntity": "Impax Laboratories (now part of. Amneal Pharmaceuticals. On May 4, 201)",
            "EstimatedSales": "USD$ 1,662 million (2018)",
            "EstimatedEmployees": "6,000 (2018)",
            "Founded": "2002"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "41-49 Colonial Drive, Piscataway,NJ 08854",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(732) 981-1412",
            "OperationStatus": "Listed as \"permanently closed\"",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "1045 Centennial Ave, Piscataway,NJ",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(732) 645-3036",
            "OperationStatus": "Operating",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "1 New England Avenue Bldg A, Piscataway, NJ,  08854",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(732) 645-3030",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "131 Chambers Brook Road Bldg A, Branchburg, NJ,  08876",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(908) 526-2446",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "65 Readington Road Bldg B, Branchburg, NJ,  08876",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(908) 526-2446",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "50 Horseblock Road, Brookhaven, NY,  11719",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(908) 231-1911",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals of New York",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Other": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "75 Adams Avenue, Hauppauge, NY,  11788",
            "Headquarters": "Bridgewater, NJ",
            "Country": "United States",
            "Phone": "(631) 952-0214",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals of New York",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Other": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "Cahir Road, Cashel, CO. Tipperary, E25 XD51, Ireland",
            "Headquarters": "Bridgewater, NJ",
            "Country": "Ireland",
            "Phone": "+353 62 27000",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Ireland Limited",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Nebule / Nebulizer / Inhalers": "MDI / DPI Inhalers",
            "Capacity / volume": "~13 million installed capacity"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "881/1-871, Village Rajoda,Taluka Bavla, Ahmedabad, Gujarat, 382220, IND",
            "Headquarters": "Bridgewater, NJ",
            "Country": "India",
            "Phone": "+91 2714 671 600",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals ",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "Plot No. 15, PHARMEZ Special Economic ZoneSarkhej-Bavla N.H. No. 8A, Vil.: Matoda, Tal.: Sanand, Ahmedabad, Gujarat, 382213, IND",
            "Headquarters": "Bridgewater, NJ",
            "Country": "India",
            "Phone": "+91 2714 677 821",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals. Parenteral Unit",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Oral solid dose overall": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "Plot No. 16 & 17, PHARMEZ Special Economic Zone,Sarkhej-Bavla N.H. No. 8A, Vil.: Matoda, Tal.: Sanand, Ahmedabad, Gujarat, 382213, IND",
            "Headquarters": "Bridgewater, NJ",
            "Country": "India",
            "Phone": "91-2717-664143",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Pharmaceuticals Oral Solid Dosage Unit",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Oral solid dose overall": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.amneal.com",
            "Address": "Plot No S-3, S-4, S-5A, TSIIC-SEZVillage-Polepally, Mandal-Jadcherla, Mahaboobnagar, Telangana, 509301, IND",
            "Headquarters": "Bridgewater, NJ",
            "Country": "India",
            "Phone": "+91 85423 02000",
            "OperationStatus": "Operating",
            "LocationAlias": "Amneal Oncology ",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.rakspharma.com",
            "Address": "Plot No 68 SY No 60,62&63 Ofe Bonamgi Revenue Village Parawada Mandal AP 008 Visakhapatam Apandhra Pradesh, 530001",
            "Headquarters": "Bridgewater, NJ",
            "Country": "India",
            "Phone": "+91 891 3081555",
            "OperationStatus": "Operating",
            "LocationAlias": "RAKS Pharma",
            "API": "Yes",
            "# of products": "~250 MT w Dahej (installed)\r\n~81 MT w Dahej (utilized)",
            "Mfg.": "Yes",
            "FDA (US)": "Yes"
        },
        {
            "Rank": "20 / 15",
            "Company": "Amneal Pharmaceuticals",
            "Ownership": "Public",
            "Website": "www.rakspharma.com",
            "Address": "Plot No Z/111/A Dahej Sez, Part II Dahej, Gujarat Bharuch-392110",
            "Headquarters": "Bridgewater, NJ",
            "Country": "India",
            "Phone": "+919909990719",
            "OperationStatus": "Operating",
            "LocationAlias": "RAKS Pharma",
            "API": "Yes",
            "# of products": "~250 MT w Vizag (installed)\r\n~81 MT w Vizag (utilized)",
            "Mfg.": "Yes",
            "FDA (US)": "Yes"
        },
        {
            "Rank": "23 / 16",
            "Company": "Glenmark",
            "Ownership": "Public: BSE:532296",
            "Website": "www.glenmarkpharma.com",
            "Address": "B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.",
            "NumberOfProducts": "135 APIs for over 200 customers in more\r\nthan 80 countries\r\nOver 130 molecules and a catalogue of over 270 inventions ",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 22 4018 9999",
            "OperationStatus": "Operating",
            "NumberOfLocations": "17 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland and 5  R&D centres in India and Switzerland",
            "RegionalEntity": "Glenmark Life Sciences (APIs)",
            "EstimatedSales": "₹104,160.65 million (2018-19)",
            "EstimatedEmployees": "14,000+",
            "Founded": "1977"
        },
        {
            "Rank": "28 / 17",
            "Company": "Torrent Pharmaceuticals",
            "Ownership": "Public: BSE:500420",
            "Website": "www.torrentpharma.com",
            "Address": "Torrent House, Off. Ashram Road, Ahmedabad - 380009, Gujarat, India",
            "NumberOfProducts": "United States: 88 ANDAs approval with 42 approvals in pipeline\r\nBrazil: 48 products approved at Anvisa with 22 of products in CNS segment, 16 in the Cardio Vascular and 10 in Oral Anti Diabetic/Obesity (OAD) segments\r\nUK: current range of over 100 molecules\r\nOthers to be determined",
            "Headquarters": "Gujarat, India",
            "Country": "India",
            "Phone": "+91-79-26599000",
            "OperationStatus": "Operating",
            "LocationAlias": "Torrent Pharma",
            "NumberOfLocations": "Nine (9) plants in India, one in the United States",
            "RegionalEntity": "Bio-Pharm, Inc. (BPI) (Levittown, PA)",
            "EstimatedSales": "₹7,673 (2018)",
            "EstimatedEmployees": "14,550",
            "Founded": "1959"
        },
        {
            "Rank": "25 / 18",
            "Company": "ENDO INTERNATIONAL PLC",
            "Ownership": "Public: Nasdaq GS:ENDP",
            "Website": "www.endo.com",
            "Address": "First Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland",
            "NumberOfProducts": "U.S. Generic Pharmaceuticals segment includes a product portfolio of over 200 generic prescription product families ",
            "Headquarters": "Dublin, Ireland",
            "Country": "Ireland",
            "Phone": "011-353-1-268-2000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Generic manufacturing in Chestnut Ridge, New York; Irvine, California and Chennai, India",
            "RegionalEntity": "Endo Pharmaceuticals\r\nPar Pharmaceutical\r\nPaladin Labs",
            "EstimatedSales": "$2.95 billion (2018)",
            "EstimatedEmployees": "2,910",
            "Founded": "1997"
        },
        {
            "Rank": "41 / 19",
            "Company": "Mallinckrodt",
            "Ownership": "Public: NYSE: MNK",
            "Website": "www.mallinckrodt.com",
            "Address": "3 Lotus Park, The Causeway, Staines-Upon-Thames,\r\nSurrey TW18 3AG, United Kingdom",
            "NumberOfProducts": "Specialty generics has 26 product families, 150+ SKUs, 10 dosage forms",
            "Headquarters": "Surry, United Kingdom",
            "Country": "United Kingdom",
            "Phone": "+44 017 8463 6700",
            "OperationStatus": "Operating",
            "NumberOfLocations": "12 manufacturing sites, including eight located in the U.S., as well as sites in Canada, Ireland and Japan\r\nprincipal executive offices are located in Saint Louis, Missouri\r\nResearch and development, manufacturing and administrative facilities are primarily conducted in Saint Louis, Missouri; Hobart, New York; Raleigh, North Carolina; Greenville, Illinois; Kobe, Japan and Sanda, Japan",
            "EstimatedSales": "$3,215.6 million (2018)",
            "EstimatedEmployees": "3,700",
            "Founded": "1867"
        },
        {
            "Rank": "* / 20",
            "Company": "Piramal Enterprises",
            "Ownership": "Public: PEL:NSI ",
            "Website": "www.piramal.com",
            "Address": "Piramal Ananata Agastya Corporate Park, Mumbai, India",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91-22-3802 3000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Pharma division, has 13 global facilities",
            "RegionalEntity": "Piramal Pharma Solutions is the Contract Development and Manufacturing Organisation (CDMO) business division\r\nPiramal Critical Care (PCC), producer of Inhaled Anesthetics and  hospital generics\r\n",
            "EstimatedSales": "₹13,215 Cr (~$1.9 Bn) (2019)",
            "EstimatedEmployees": "7,820",
            "Founded": "1980",
            "CMO / CMDO": "Yes"
        },
        {
            "Rank": "5",
            "Company": "Perrigo ",
            "Ownership": "Public: NYSE:PRGO",
            "Website": "www.perrigo.com",
            "Address": "The Sharp Building, Hogan Place, Dublin 2, Ireland",
            "NumberOfProducts": "14,000+ Stock Keeping Units and 3,000+\r\nProduct Formulations",
            "Headquarters": "Dublin, Ireland",
            "Country": "Ireland",
            "Phone": "+353 1 7094000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "26 Manufacturing & Packaging Facilities",
            "EstimatedSales": "$4,731.7 million (2018)",
            "EstimatedEmployees": "10,600"
        },
        {
            "Rank": "9",
            "Company": "Fosun Pharma ",
            "Ownership": "Public: SHSE:600196",
            "Website": "www.fosunpharma.com",
            "Address": "9th Floor, No. 510 Caoyang Road\r\nPutuo District, Shanghai, 200063, China",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Shanghai, China",
            "Country": "China",
            "Phone": "+86-21-33987000",
            "OperationStatus": "Operating",
            "LocationAlias": "Shanghai Fosun Pharmaceutical",
            "NumberOfLocations": "To be determined\r\nJiangsu Wanbang Biochemical Pharmaceutical has more than 10 production lines\r\nYaopharma has 8 production locations",
            "RegionalEntity": "Pharmaceutical Subsidiaries\r\n* Gland Pharma \r\n* Jiangsu Wanbang Biopharmaceuticals\r\n* YAOPHARMA\r\n* Guilin Pharmaceutical \r\nR&D Subsidiaries\r\n* Shanghai Henlius Biotech\r\n* Chongqing Fuchuang Pharmaceutical Research \r\n* Novostar\r\n*Fosun Hongchuang Pharmaceutical Technology \r\n* Fosun Lingzhi (Shanghai) Pharmaceutical Technology\r\n* Fosun Kate Biological Technology",
            "EstimatedSales": "24,714 RMB Million (2018)",
            "EstimatedEmployees": "28,245 globally"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "www.intaspharma.com",
            "Address": "Nr. Sola Bridge, S. G. Highway, Thaltej, Ahmedabad – 380 054",
            "NumberOfProducts": "Has over 10,000 product registrations worldwide\r\n8,500+ product registrations in the European market",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91 79 3983 7000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Operates thirteen manufacturing facilities, of which ten are located in India and the rest in UK and Mexico",
            "RegionalEntity": "Accord Healthcare Sage House, 319 Pinner Road, , , , North Harrow, London, HA1 4HF",
            "EstimatedSales": "$1.9 billion (2019)",
            "EstimatedEmployees": "10,001+"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.accord-healthcare.com/uk/",
            "Address": "Sage House, 319 Pinner Road, , , , North Harrow, London, HA1 4HF",
            "NumberOfProducts": "6,000 products sold across Europe, portfolio of over 200 molecules across multiple therapeutic classes",
            "Headquarters": "London, UK",
            "Country": "United Kingdom",
            "Phone": "+44 208 863 1427",
            "OperationStatus": "Operating",
            "LocationAlias": "Harrow - Accord Healthcare",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Regional HQ": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Ampoules": "Yes",
            "Vials": "Yes",
            "Powders": "Yes",
            "Liquids (non-injectables)": "Yes",
            "Nebule / Nebulizer / Inhalers": "Yes",
            "Oral solutions": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "Sprays": "Yes",
            "Transdermal patches": "Yes",
            "Other": "* Infusion bags\r\n* Prefilled syringe\r\n* Nail laquer",
            "cGMP ": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Sage House, 319 Pinner Road, , , , North Harrow, London, HA1 4HF",
            "Headquarters": "Ahmedabad, India",
            "Country": "United Kingdom",
            "Phone": "+44 208 863 1427",
            "OperationStatus": "Operating",
            "LocationAlias": "Harrow",
            "API": "Yes",
            "Regional HQ": "Yes",
            "Labs / R&D / Technology Center": "Drug testing",
            "Other": "Release site",
            "Mfg.": "NO",
            "cGMP ": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Whiddon Valley, , , , Barnstaple, Devon, EX32 8NS",
            "Headquarters": "Ahmedabad, India",
            "Country": "United Kingdom",
            "Phone": "+44 (0)191 213 3800\r\n+44 (0)191 213 3802",
            "OperationStatus": "Operating",
            "LocationAlias": "Barnstaple",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "cGMP ": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Edgefield Avenue, , , , Fawdon, New Castle, NE3 3NB",
            "Headquarters": "Ahmedabad, India",
            "Country": "United Kingdom",
            "OperationStatus": "Operating",
            "LocationAlias": "Fawdon",
            "Land": "55,000 m2",
            "PlantFacility ": "19,000 m2",
            "Warehouse": "4,000 pallets",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Oral solid dose overall": "Yes",
            "Tablets": "Yes",
            "Capacity / volume": "Over 5 billion tabs / 5.3 billion packed",
            "cGMP ": "Yes",
            "Comment": "Molecules: 11 controlled drug, 7 high potency, 10 development, 63 others, 730 SKU's"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Unit-C, Homefield Road, , , , Haverhill, Cambridge, Suffolk, CB9 8QP",
            "Headquarters": "Ahmedabad, India",
            "Country": "United Kingdom",
            "Phone": "+44 (0) 1440-766399",
            "OperationStatus": "Closed June 2019",
            "LocationAlias": "Haverhill",
            "EstimatedEmployees": "84",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Oral solid dose overall": "Yes",
            "cGMP ": "Yes",
            "EU-GMP (EU)": "Yes",
            "GDP (EU)": "Yes",
            "Comment": "Importing, storage, and distribution of finished products across the EU region"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Oxfordshire",
            "Headquarters": "Ahmedabad, India",
            "Country": "United Kingdom",
            "OperationStatus": "Under Construction as of Sept 2019",
            "LocationAlias": "Didcot",
            "Warehouse": "200,000 sq. ft",
            "VolumeCapacityOverview": "30,000 pallets",
            "Other": "Distribution",
            "Mfg.": "NO",
            "Comment": "Supports existing sites in Barnstaple and Fawdon.\r\nWhen fully operational it will distribute in excess of 1,000,000 packs per day"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "2702/A, GIDC Industrial Estate, District Bharuch, Ankleshwar, Gujarat, 393002",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "Land": "17,520 m2",
            "VolumeCapacityOverview": "Total production capacity of 83.3 Kg/Month",
            "Mfg.": "Yes",
            "Chemicals /raw materials": "Yes",
            "Other": "Yes",
            "Plant details": "Manufacturing of proposed products involve various unit operations like distillation, extraction, filtration, centrifugation, crystallization, precipitation, isolation and drying etc. and unit process mainly fermentation (based on proposed expansion plan July 2017)"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Camp Road, , , Selaqui, Dohradun, Uttrakhand, 248001",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-135-2698659, 2699098, 2699174, 2699175",
            "OperationStatus": "Operating",
            "LocationAlias": "Dehradun",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "cGMP ": "Yes",
            "Comment": "This facility caters to India and Semi-regulated markets like Asia-Pacific, Africa, Latin America, etc."
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Near IOC Depo, N.H. No. 31A, , , Bhagey Khola, Majhitar, Rangpo, East Sikkim, 737132",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-03592-246417, 18, 32 ",
            "OperationStatus": "Operating",
            "LocationAlias": "Sikkim",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Comment": "Caters to Domestic and Semi-regulated markets like Asia-Pacific, Africa, Latin America, etc."
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "85 - 87, Kailash Industrial Estate, , Iyava Village, Sanand Taluka, Ahmedabad, Gujarat, 38210",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-02717-284188, 89, 90\r\nMobile: +91-89807 76456 (Mr. Sudhir Mhatre)",
            "OperationStatus": "Operating",
            "LocationAlias": "Sanand",
            "Land": "19,000 sq. mts.",
            "PlantFacility ": "4,050 sq. mts.",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Survey No. 44-B, , , Naldhari Village, Valia Taluka, Ankleshwar, Gujarat, 393135",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91 02643-270015, 270389",
            "OperationStatus": "Operating",
            "LocationAlias": "Ankleshwar",
            "Land": "47,923 sq. mts",
            "API": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "7/3, GIDC Estate, , , B/H Dena Bank, Vatva, Ahmedabad, Gujarat, 382445",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-79-25830207",
            "OperationStatus": "Operating",
            "LocationAlias": "Vatva",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Comment": "This facility caters to India and Semi-regulated markets"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Plot No. 457, 458, Sarkhej Bavla Highway, , Village Matoda, Taluka Sanad, Matoda Village, Ahmedabad, Gujarat, 382210",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-2717-661298",
            "OperationStatus": "Operating",
            "LocationAlias": "Matoda",
            "Land": "1,01,171 sq. mts",
            "API": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Other": "API site",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Oral solid dose overall": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "ANVISA (BR)": "Yes",
            "cGMP ": "Yes",
            "FDA (US)": "Yes",
            "GCC (SA)": "Yes",
            "MCC (ZA)": "Yes",
            "MHRA (UK)": "Yes",
            "TGA (AU)": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Plot No. 423/P/A/ GIDC, Sarkhej-Bavla Highway,  Moraiya, Sanand Taluka, Ahmedabad, Gujarat, 382210",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-2717-660100, 660101",
            "OperationStatus": "Operating",
            "LocationAlias": "Moraiya",
            "PlantFacility ": "100,000 sq. ft",
            "Biosimilars / Biologicals": "Yes",
            "CMO / CMDO": "Yes",
            "Other": "Biotech facility",
            "Cartridges": "Yes",
            "Capacity / volume": "20,000-50,000 (liquid)",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Vials": "Yes",
            "Pre-filled syringes (PFS)": "Yes",
            "ANVISA (BR)": "Yes",
            "cGMP ": "Yes",
            "EU-GMP (EU)": "Yes",
            "GCC (SA)": "Yes",
            "MCC (ZA)": "Yes",
            "Bioreactor": "Yes",
            "Bioreactor volume": "100L (Microbial Suite #1)\r\n50L (Microbial Suite #2)\r\n50L (Microbial Suite #2)\r\n150L (Mammalian Suite #1)\r\n150L (Mammalian Suite #2)\r\n20L (Protein Pegylation)\r\n50L (Protein Pegylation)",
            "Plant details": "Multiple Class 10,000 stainless steel bioreactor suites for mammalian cell cultures\r\nClass 10,000 complete disposable bioreactor suite for mammalian cell cultures\r\nMultiple Class 10,000 purification suites for downstream processing\r\nClass 100 suite each for filling into pre-filled syringes, vials and cartridges\r\nClass 10,000 suite for pegylated products manufacturing\r\nIn-house facilities for visual inspection of finished goods, packaging, and dispatch\r\nCold rooms with continuous temperature monitoring for storage of bulk intermediates, semi-finished and finished products\r\nSeparate facilities housing automated stainless steel tanks for media and buffer preparation needs\r\nContinuously monitored utility systems (water-for-injection, steam, chilled water, compressed air etc) to support process requirements\r\nThe facilities are designed to accommodate future capacity enhancement and are continuously monitored by facility monitoring and building management systems",
            "Comment": "Integrated multi-product manufacturing facility for biosimilars, seamlessly carries-out bulk-drug manufacturing, protein & antibody purification, pegylation, lyophilization, aseptic fill-finish activity for pre-filled syringes, vials and cartridge for pen devices"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Plot No. 496/1/A & B, Sarkhej-Bavla Highway Village: Matoda, Taluka: Sanand Ahmedabad GJ 382210",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91 02717-251188/660100",
            "OperationStatus": "Operating",
            "LocationAlias": "Celestial / CELESTIAL BIOLOGICALS LIMITED",
            "Biosimilars / Biologicals": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Survey No 44 B, Valia, Bharuch - 393135, Village Naldhari",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91 2642 270015",
            "OperationStatus": "Operating",
            "LocationAlias": "Valia",
            "API": "Yes",
            "FDA (US)": "Yes"
        },
        {
            "Rank": "13",
            "Company": "Intas Pharma",
            "Ownership": "Private Company",
            "Website": "https://www.intaspharma.com",
            "Address": "Plot No. 5, 6, 7, Pharmez, Sarkhej-Bavla Highway, , Matoda Village, Sanand Taluka, Ahmedabad, Gujarat, 382210",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-02717-619700",
            "OperationStatus": "Operating",
            "LocationAlias": "PharmEZ",
            "Land": "35,565 sq. mts",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "ANVISA (BR)": "Yes",
            "cGMP ": "Yes",
            "FDA (US)": "Yes",
            "Comment": "Caters exclusively to the US, Europe and other regulated markets"
        },
        {
            "Rank": "18",
            "Company": "Zydus Cadila",
            "Ownership": "Public: BSE:532321",
            "Website": "https://zyduscadila.com",
            "Address": "Zydus Tower, Satellite Cross Road, Sarkhej-Gandhinagar Highway, Ahmedabad - 380 015",
            "NumberOfProducts": "US: Filed 26 Abbreviated New Drug Applications (ANDAs) with the USFDA and > 330 cumulative ANDA filings",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-79-2686 8100",
            "OperationStatus": "Operating",
            "NumberOfLocations": "More than 30 manufacturing plants worldwide including India, Germany, Brazil & USA",
            "RegionalEntity": "Cadila Healthcare Ltd.\r\nZydus Takeda Healthcare\r\nZydus Hospira Oncology \r\nBayer Zydus Pharma",
            "EstimatedSales": "₹ 119 billion INR (2018)",
            "EstimatedEmployees": "11,819"
        },
        {
            "Rank": "19",
            "Company": "KrKa",
            "Ownership": "Public: LJSE:KRKG",
            "Website": "www.krka.biz",
            "Address": "Smarjeska Cesta 6, Novo Mesto, Slovenia",
            "NumberOfProducts": "Generics the company has over 350 patent protected innovations \r\nNew marketing authorisations: 23 products in 52 pharmaceutical dosage forms and strengths\r\n",
            "Headquarters": "Novo Mesto, Slovenia",
            "Country": "Slovenia",
            "Phone": "+386 7 331 21 11",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Production takes place in Slovenia, Poland, the Russian Federation, Croatia and Germany",
            "RegionalEntity": "Company has over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.",
            "EstimatedSales": "€1,331.9 million (2018)",
            "EstimatedEmployees": "Over 12,000"
        },
        {
            "Rank": "21",
            "Company": "Nichi-Iko Pharmaceutical ",
            "Ownership": "Public: 4541 (TYO)",
            "Website": "www.nichiiko.co.jp/",
            "Address": "1-6-21 Sogawa, Toyama City, Toyama Prefecture, Japan\r\n\r\n5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Toyama Prefecture, Japan\r\n\r\nTokyo, Japan",
            "Country": "Japan",
            "Phone": "Toyama +81-76-432-2121\r\n\r\nTokyo +81-3-3276-0215",
            "OperationStatus": "Operating",
            "NumberOfLocations": "9 manufacturing plants\r\nHokkaido Plant (Antiseptics)\r\nYamagata Plant (External)\r\nSaitama Plant (Oral Jelly, Eye Drop & Divided Liquid)\r\nShizuoka Plant (Tablets, Capsules, Granules & Injections)\r\nAichi Plant (Injections)\r\nToyama Plant 1 (Tablets & Capsules)\r\nToyama Plant 2 (Powders & Granules)\r\nCanada Omega Plant（Injections）\r\nUSA Raleigh Plant（Injections）",
            "RegionalEntity": "Overseas Subsidiaries\t\r\nSagent Pharmaceuticals［USA］\r\nOmega Laboratories［Canada］\r\nNIXS Corporation [USA]\r\nNichi-Iko（Thailand [Thailand]\r\nLocal Subsidiaries\r\n(Head Office Site)\tElmed  [Toyama]\r\nYakuhan Pharmaceutical [Hokkaido]\r\nEMI Inc. [Osaka]\r\nNichi-Iko Osaka . [Osaka]",
            "EstimatedSales": "Yen 166,592 million (2019)",
            "EstimatedEmployees": "1,573",
            "Founded": "1965"
        },
        {
            "Rank": "22",
            "Company": "Aspen Pharmacare",
            "Ownership": "Public: JSE:APN",
            "Website": "www.aspenpharma.com",
            "Address": "9 Rydall Vale Park\r\nDouglas Saunders Drive\r\nLa Lucia Ridge, Durbin, South Africa",
            "NumberOfProducts": "More than 24 billion tablets manufactured annually To be determined",
            "Headquarters": "Durbin, South Africa",
            "Country": "South Africa",
            "Phone": "+27 31 580-8600",
            "OperationStatus": "Operating",
            "NumberOfLocations": "25 manufacturing facilities on 17 sites",
            "RegionalEntity": "Apen OSS",
            "EstimatedSales": "R12,329 million (2019)",
            "EstimatedEmployees": "Approximately 10,000"
        },
        {
            "Rank": "22",
            "Company": "Aspen Pharmacare",
            "Ownership": "Public: JSE:APN",
            "Website": "www.aspenoss.com",
            "Address": "Veersemeer 4, 5347 JN Oss, Netherlands",
            "Headquarters": "Durbin, South Africa",
            "Country": "Netherlands",
            "Phone": "+31 88 277 9000",
            "OperationStatus": "Operating",
            "LocationAlias": "Aspen Oss B.V. / DIOSITE (\"DE GEER\") SITE",
            "API": "Yes",
            "Mfg.": "Yes",
            "ANVISA (BR)": "Yes",
            "DG - SANCO / EMA (EU)": "Yes",
            "FDA (US)": "Yes",
            "KFDA / MFDS (KR)": "Yes",
            "PMDA (JP)": "Yes"
        },
        {
            "Rank": "22",
            "Company": "Aspen Pharmacare",
            "Ownership": "Public: JSE:APN",
            "Website": "www.aspenoss.com",
            "Address": "Molenstraat 10, 5340 CC Oss Netherlands",
            "Headquarters": "Durbin, South Africa",
            "Country": "Netherlands",
            "Phone": "+31 (0) 88 2779 000",
            "OperationStatus": "Operating",
            "LocationAlias": "Aspen Oss B.V. / MOLENEIND SITE",
            "API": "Yes",
            "Mfg.": "Yes",
            "ANVISA (BR)": "Yes",
            "DG - SANCO / EMA (EU)": "Yes",
            "FDA (US)": "Yes",
            "KFDA / MFDS (KR)": "Yes",
            "PMDA (JP)": "Yes"
        },
        {
            "Rank": "22",
            "Company": "Aspen Pharmacare",
            "Ownership": "Public: JSE:APN",
            "Website": "www.aspenoss.com",
            "Address": "Korenmolen 6, 5281 RM Boxtel Netherlands",
            "Headquarters": "Durbin, South Africa",
            "Country": "Netherlands",
            "Phone": "+31 412 666903",
            "OperationStatus": "Operating",
            "LocationAlias": "Aspen Oss B.V. / BOXTEL SITE",
            "API": "Yes",
            "Mfg.": "Yes",
            "DG - SANCO / EMA (EU)": "Yes",
            "FDA (US)": "Yes",
            "PMDA (JP)": "Yes"
        },
        {
            "Rank": "23",
            "Company": "Gedeon Richter",
            "Ownership": "Public: BUSE:RICHTER",
            "Website": "www.richter.hu",
            "Address": "Gyomroi Ut 19-21, Budapest, Hungary",
            "NumberOfProducts": "Manufactures more than 200 medicines that  include original, generic and licenced products\r\nOver 2000 varieties: solid, liquid, soft gell, tablets, coated and filmed tablets, sprays, creams and other forms",
            "Headquarters": "Budapest, Hungary",
            "Country": "Hungary",
            "Phone": "(36) 1-431-4000",
            "OperationStatus": "Operating",
            "LocationAlias": " ",
            "NumberOfLocations": "Produces medicines in Hungary, Romania, Russia, Poland, Germany and India",
            "RegionalEntity": "Gedeon Richter Polska\r\nRichter-Helm BioLogics and BioTec\r\nGedeon Richter RUS\r\nGedeon Richter Romania\r\nRichter Themis\r\nGedeon Richter",
            "EstimatedSales": "1.57 billion USD (2018)",
            "EstimatedEmployees": "12,696"
        },
        {
            "Rank": "26",
            "Company": "Bausch Health",
            "Ownership": "Public: NYSE:BHC and TSX: BHC",
            "Website": "www.bauschhealth.com",
            "Address": "2150 St. Elzéar Blvd. West\r\nLaval, Quebec H7L 4A8 Canada",
            "NumberOfProducts": "Approximately 1,500 products its product portfolio across all of its segments Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products\r\nIt also subcontracts the manufacturing of certain products",
            "Headquarters": "Laval, Quebec, Canada",
            "Country": "Canada",
            "Phone": "(800) 361-1448\r\n(514) 744-6792",
            "OperationStatus": "Operating",
            "LocationAlias": "Formerly Valeant Pharmaceuticals International",
            "NumberOfLocations": "Approximately 38 manufacturing plants worldwide ",
            "RegionalEntity": "The Bausch + Lomb\r\n",
            "EstimatedSales": "$8,380 million",
            "EstimatedEmployees": "21,100",
            "Founded": "2000"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013, Maharashtra",
            "NumberOfProducts": "800 brands covering all the major therapeutic segments\r\n70 ANDA approvals",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 22 3982 9999",
            "OperationStatus": "Operating",
            "NumberOfLocations": "21 manufacturing facilities and 5 R&D centers located across India and the US",
            "RegionalEntity": "As on 31st March, 2019, the Company had 20 subsidiaries.",
            "EstimatedSales": " ₹73,572 mn (2018)",
            "EstimatedEmployees": ">14,500 worldwide"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.noracpharma.com",
            "Address": "405 S Motor Ave, Azusa, CA 91702",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "(626) 334-2908",
            "OperationStatus": "Operating",
            "LocationAlias": "Norac Pharma",
            "EstimatedEmployees": "51-200",
            "API": "Yes",
            "CMO / CMDO": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Other": "Yes",
            "Mfg.": "Yes",
            "FDA (US)": "Yes",
            "Comment": "(Controlled substances - Sch. I, II, III), contract research"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "1733 Gilsinn Ln, Fenton (St. Louis), MO 63026",
            "Headquarters": "Mumbai, India",
            "Country": "United States",
            "Phone": "(636) 343-5664",
            "OperationStatus": "Operating",
            "LocationAlias": "S&B Pharma",
            "EstimatedEmployees": "94",
            "PlantFacility ": "75,000 sq. ft.",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Liquids (non-injectables)": "Yes",
            "Sprays": "Nasal - B12",
            "FDA (US)": "Yes",
            "Comment": "DEA registered facility (controlled substances - SCh.II-V)"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Plot No. 165/1/26, T-Block, MIDC, Bhosari, Pune, India",
            "Headquarters": "Maharashtra, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Enzene-Biosciences",
            "Biosimilars / Biologicals": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "659/B, Somnath Kevdi Road,\r\nDaman - 396210, Daman and Diu",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91-260-2242239/22240020",
            "OperationStatus": "Operating",
            "LocationAlias": "Indchemie Health Specialities (Unit-1 Daman)",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Plot No.: 7, OIDC,\r\nMahatma Gandhi Udyog Nagar,\r\nDabhel, Daman - 396210",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Indchemie Health Specialities (Unit-2 Daman)",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Soft Gelatin"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Vill. Thana, Distt. Solan, Thana, Baddi, Himachal Pradesh, 173205",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 01795-308300, 314",
            "OperationStatus": "Operating",
            "LocationAlias": "Indchemie Health Specialities (Baddi)",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Liquids (non-injectables)": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "Other": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Unit-IV, Kumrek, Rangpo, East Sikkim- 737132",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit IV - Indchemie Health Specialities (Sikkim)",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Unit I & II, Kumrek, Rangpo, East Sikkim- 737132",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit I & II, Indchemie Health Specialities (Sikkim)",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Unit-III, Baddi, Himachal Pradesh",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit III Indchemie Health Specialities (Unit III)",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.cachetindia.com",
            "Address": "Village-Thana, Dist-Solan, Baddi, Himachal Pradesh, 173205",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 99311 48180 / 91-1795-308142",
            "OperationStatus": "Operating",
            "LocationAlias": "Cachet Pharmaceuticals Private Limited",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.cachetindia.com",
            "Address": "C 582, Riico Industry Area, Alwar dist, Riico Industry Area,,\r\nBhiwadi-301019, Rajasthan",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Cachet Pharmaceuticals Private Limited",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Namchi - Namthang Rd, Agam Gram, Namchi, Sikkim 737126",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 70635 91112",
            "OperationStatus": "Construction completed in 2016",
            "LocationAlias": "Cachet Pharmaceuticals Private Limited",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Post Naugama, National highway.No.8, Mandava, Ankleshwar, Dist.Bharuch - 393010, Gujarat",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+919558805290",
            "OperationStatus": "Operating",
            "LocationAlias": "Mandva Plant",
            "API": "Yes",
            "Mfg.": "Yes",
            "FDA (US)": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Plot No 289-290, GIDC Industrial Estate, Ankleshwar,, Bharuch, Gujarat, 393 002, IND",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Ankleshwar Plant",
            "API": "Yes",
            "Mfg.": "Yes",
            "FDA (US)": "Yes",
            "TGA (AU)": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "(Amaliya, Daman) 167/1 Mahatma GIDC, Gandhi Udyg Ngr Dabhel Daman, Dabhel, Daman - 396215",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91-260-3982835/3982874",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit 1",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Liquids (non-injectables)": "Suspensions",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "(Amaliya, Daman) 167/2 Mahatma Gandhi Udyg Ngr Dabhel Daman, Dabhel, Daman - 396215",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91-260-3982818",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit 2",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Liquids (non-injectables)": "Suspensions",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Unit 1,2 Purana Barrier, Village-Thane, Dist Solan, Baddi, Himachal Pradesh 173205",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit I & II",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Kumrek, Nh 31a, Rangpokhola, East Sikkim,  737132",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 73109 92531",
            "OperationStatus": "Operating",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "Samardung, Karek Block, PO-Namthang, Dist-South Sikkim 737137",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "LocationAlias": "Unit I, II & III Alkem Health Science A Unit Of Alkem Laboratories",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "N.H.(National Highway) No.8, Mandva, Dist-Bharuch, Gujarat",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+919558805290",
            "OperationStatus": "Operating",
            "Mfg.": "Yes"
        },
        {
            "Rank": "27",
            "Company": "Alkem Laboratories Ltd.",
            "Ownership": "Public: ALKEM (NSE)",
            "Website": "www.alkemlabs.com",
            "Address": "333/1, Silicon Industrial Estate, Near Patel Cricket Ground, Kashtigam, Daman, Daman and Diu ",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "OperationStatus": "Operating",
            "Mfg.": "Yes"
        },
        {
            "Rank": "29",
            "Company": "Hypera Pharma ",
            "Ownership": "Public: BOVESPA:HYPE3",
            "Website": "www.hyperapharma.com.br",
            "Address": "Av. Magalhães de Castro, 4800 - 24° andar - Edifício Continental Tower - Bairro Cidade Jardim - CEP 05676-120",
            "NumberOfProducts": "300+ brands sold all over Brazil",
            "Headquarters": "Jardim, Brazil",
            "Country": "Brazil",
            "Phone": "(11) 3627-5674 / 5659/5605/4331/5429",
            "OperationStatus": "Operating",
            "LocationAlias": "Formerly Hypermarcas",
            "NumberOfLocations": "Production complex located at Anápolis, Goiás",
            "RegionalEntity": "Neo Quimica (Trade / POS)\r\nMantecorp Farmasa (RX)\r\nMantecorp Skincare (RX)\r\nConsumer Heath (consumer healthcare)",
            "EstimatedSales": "R$3,724.3 million (2018 net revenue)",
            "EstimatedEmployees": "6,500"
        },
        {
            "Rank": "30",
            "Company": "Towa Pharmaceutical",
            "Ownership": "Public (TSE: 4553)",
            "Website": "www.towayakuhin.co.jp",
            "Address": "2-11, Shinbashi-cho, Kadoma, Osaka 571-8580 JAPAN",
            "NumberOfProducts": "761 products (as of June 2019)",
            "Headquarters": "Osaka, Japan",
            "Country": "Japan",
            "Phone": "+81(0)6-6900-9100",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Three (3) plants in Japan ",
            "RegionalEntity": "J-DOLPH Pharmaceutical (Manufacture and sale of ethical drugs)\r\nDaichi Kasei (R&D and production of active pharmaceutical ingredients and intermediates)\r\nGreencaps Pharmaceutical (Production of ethicaldrugs of soft capsules)\r\nT Square Solutions (Delivery and relevant business of IT service associated with healthcare)",
            "EstimatedSales": "Yen 105,104 million (2018)",
            "EstimatedEmployees": "3,159",
            "Founded": "1951"
        },
        {
            "Rank": "31",
            "Company": "Celltrion",
            "Ownership": "Public: KOSDAQ:A068270",
            "Website": "www.celltrion.com",
            "Address": "23 Academy-ro, Yeonsu-gu, Incheon Metropolitan City  ",
            "NumberOfProducts": "Forty-two (42) approved drug products in the US",
            "Headquarters": "Incheon Metropolitan City, South Korea",
            "Country": "South Korea",
            "Phone": "032-850-5000\r\n+82-32-850-6400",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Plants in Songdo, Incheon, Korea ",
            "EstimatedSales": "$822.5 million (2018)",
            "EstimatedEmployees": "1,942",
            "Biosimilars / Biologicals": "Yes",
            "CMO / CMDO": "Yes"
        },
        {
            "Rank": "32",
            "Company": "Aché Laboratórios",
            "Ownership": "Private Company",
            "Website": "www.ache.com.br",
            "Address": "Rodovia Presidente Dutra, Km 222, 2 - Guarulhos, GUARULHOS, SP 07034904, BR",
            "NumberOfProducts": "358 brands, 871 SKUs and 145 therapeutic classes, in the prescription, generic, over-the-counter (OTC), dermocosmetics, dermatological drugs, nutraceuticals, probiotics and biotechnology",
            "Headquarters": "San Paulo, Brazil",
            "Country": "Brazil",
            "Phone": "55-11-2608-6000",
            "OperationStatus": "Operating",
            "LocationAlias": "Ache Laboratorios Farmaceuticos SA",
            "NumberOfLocations": "Industrial plants: São Paulo - SP; Guarulhos - SP; Londrina - PR (Nortis); and Anápolis - GO\r\nBionovis (a joint-venture with three other national pharmaceutical companies), located in Valinhos - SP, dedicated to the research and development of biotechnological drugs\r\nNew industrial plant is under construction, located in Cabo de Santo Agostinho, Pernambuc",
            "EstimatedSales": "Net revenue R$ 3.2 billlion (2018)",
            "EstimatedEmployees": "4,700"
        },
        {
            "Rank": "33",
            "Company": "Akorn \r\n(19 Dec 2019) Reported it is considering bankrupcy and Agrees Temporary Standstill With Lenders until 7 February 2020",
            "Ownership": "Public: NasdaqGS:AKRX",
            "Website": "www.akorn.com",
            "Address": "1925 W. Field Court, Suite 300, Lake Forest, Illinois 60045",
            "NumberOfProducts": "Approximately 176 generic products. Company also produces consumer health products",
            "Headquarters": "Lake Forest, IL",
            "Country": "United States",
            "Phone": "(847) 279-6100",
            "OperationStatus": "Operating",
            "NumberOfLocations": "•Somerset, New Jersey — sterile ophthalmic solutions, ointments and gels\r\n•Decatur, Illinois — sterile liquid and lyophilized injectables and sterile ophthalmic solutions\r\n•Amityville, New York — sterile ophthalmic and otic solutions, sterile gels, and non-sterile nasal sprays, topical ointments and creams, oral liquids, and liquid unit dose cups\r\n•Hettlingen, Switzerland — sterile ophthalmic solutions, suspensions, gels and ointments\r\n•Paonta Sahib, Himachal Pradesh, India — sterile liquid injectables including cephalosporins, carbapenems, hormones and general injectables",
            "EstimatedSales": "$694,018,000 (2018)",
            "EstimatedEmployees": "2,220"
        },
        {
            "Rank": "34",
            "Company": "Lannett Company",
            "Ownership": "Public: NYSE: LCI",
            "Website": "www.lannett.com/",
            "Address": "9000 State Road, Philadelphia, PA 19136",
            "NumberOfProducts": "Over 100 unique pharmaceutical product families",
            "Headquarters": "Philadelphia, PA",
            "Country": "United States",
            "Phone": "(215) 333-9000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Seymour, Indiana\r\nCarmel, New York\r\nSeveral locations in Philadelphia, PA",
            "RegionalEntity": "Kremers Urban Pharmaceuticals, Inc\r\nSilarx Pharmaceuticals, Inc\r\nCody Laboratories (APIs)",
            "EstimatedSales": "$655,407,000 (2019)",
            "EstimatedEmployees": "1,020",
            "Founded": "1942"
        },
        {
            "Rank": "35",
            "Company": "Sopharma AD",
            "Ownership": "Public: SPH (WSE)",
            "Website": "www.sopharmagroup.com",
            "Address": "5 Lachezar Stanchev Str.\r\nSopharma Business Towers\r\nbuilding A, fl. 11 1756 Sofia",
            "NumberOfProducts": "15 traditional herbal products\r\n210 generic products in the Group",
            "Headquarters": "Sofia, Bulgaria",
            "Country": "Bulgaria",
            "Phone": "+3592 8134 319",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Production facilities:\r\nSofia\r\nVrabevo\r\nKazanlak\r\nSliven\r\nVeliko Tarnovo\r\nSandanski",
            "RegionalEntity": "As at 30 June 2019 Sopharma Group consists of:\r\nSopharma AD and\r\n54 legal entities including:\r\n53 subsidiaries directly or indirectly controlled by Sopharma AD;\r\n1 joint venture",
            "EstimatedSales": "BGN 1,179,143 ('000') (2018)",
            "EstimatedEmployees": "5,075",
            "Founded": "1933"
        },
        {
            "Rank": "36",
            "Company": "Wockhardt",
            "Ownership": "Public: BRSE:WBIO",
            "Website": "www.wockhardt.com",
            "Address": "Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India",
            "NumberOfProducts": "Portfolio of generic drugs, which includes approximately 600 pharmaceuticals in various dosages and form",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 22 2653 4444",
            "OperationStatus": "Operating",
            "NumberOfLocations": " 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines",
            "EstimatedSales": "INR 41,399,400,000 (2018)",
            "EstimatedEmployees": "8,600"
        },
        {
            "Rank": "37",
            "Company": "Orion Corporation",
            "Ownership": "Public: Nasdaq Helsinki",
            "Website": "https://www.orion.fi/",
            "Address": "Orionintie 1A, 02200 Espoo, PO Box 65, FI-02101 Espoo, Finland",
            "NumberOfProducts": "Orion's Speciality products portfolio consists of a range of over 300 generic prescription and OTC drugs",
            "Headquarters": "Espoo, Finland",
            "Country": "Finland",
            "Phone": "+358 10 4261",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Six (6) manufacturing sites in Finland",
            "EstimatedSales": "977 MEUR (2018)",
            "EstimatedEmployees": "3,154",
            "Founded": "1917"
        },
        {
            "Rank": "38",
            "Company": "Advanz Pharma",
            "Ownership": "Public: CXRXF (OTCMKTS) Majority owned by GSO Capital (part of the Blackstone Majority Group)",
            "Website": "www.advanzpharma.com",
            "Address": "Capital House, 1st Floor, 85 King William Street, London EC4N 7BL, United Kingdom",
            "NumberOfProducts": "190+ legacy brands and niche generic medications across 900+ individual SKUs",
            "Headquarters": "London, UK",
            "Country": "United Kingdom",
            "Phone": "+44 (0) 208 588 9100",
            "OperationStatus": "Operating",
            "NumberOfLocations": "To be determined. Company has 70 active CMOs",
            "EstimatedSales": "520 LTM (2018)",
            "EstimatedEmployees": "To be determined",
            "Founded": "1963"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubl.com",
            "Address": "Bhartiagram, Gajraula, Distt. Amroha - 244223, Uttar Pradesh",
            "NumberOfProducts": "42 commercial API products, 55 commercialised generic products, 60+ commercial specialty intermediates, ",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 120 4361000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "11 Manufacturing Facilities (7 in India, 2 in Canada and 2 in USA )",
            "RegionalEntity": "Jubilant Pharma Limited\r\n",
            "EstimatedSales": "US $ 1310 Mn\r\n(INR 9,111 Crs) (2019)",
            "EstimatedEmployees": "8,000",
            "Founded": "1978",
            "Global HQ": "Yes"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubilantpharma.com",
            "Address": "16751, TransCanada Highway, Kirkland (Montreal), Québec, H9H 4J4",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "Canada",
            "Phone": "+514 630 7030",
            "OperationStatus": "Operating",
            "LocationAlias": "Jubilant DraxImage, Jubilant Pharma Limited ",
            "API": "Yes",
            "CMO / CMDO": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "FDA (US)": "Yes",
            "HPFB-HC (CA)": "Yes",
            "Comment": "Health Canada and the US FDA approved facility for Radiopharmaceuticals"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubilantpharma.com",
            "Address": "207 Kiley Drive, Salisbury, Salisbury, MD, 21801",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "United States",
            "Phone": "+1 410 860 8500",
            "OperationStatus": "Operating",
            "LocationAlias": "Jubilant Cadista Pharmaceuticals, Jubilant Pharma Limited ",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "DEA (US)": "Yes",
            "FDA (US)": "Yes",
            "HPFB-HC (CA)": "Yes",
            "Comment": "Health Canada, US FDA and DEA approved facility for Solid Dosage Formulations"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubilantpharma.com",
            "Address": "3525, N. Regal, Spokane, WA, 99207",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "United States",
            "Phone": "+1 509 489 5656",
            "OperationStatus": "Operating",
            "LocationAlias": "Jubilant HollisterStier LLC",
            "CMO / CMDO": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "FDA (US)": "Yes",
            "HPFB-HC (CA)": "Yes",
            "MHRA (UK)": "Yes",
            "PMDA (JP)": "Yes",
            "Comment": "US FDA, MHRA, Health Canada, PMDA Japan approved facility for Sterile Injectables\r\nUS FDA and Health Canada approved facility for Allergy Therapy products"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Jubilant Life Sciences",
            "Website": "www.jublhs.com",
            "Address": "16751 Trans Canada Highway, Kirkland (Montreal), Québec, H9H 4J4",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "Canada",
            "Phone": "514.694.8220",
            "OperationStatus": "Operating",
            "LocationAlias": "Jubilant HollisterStier",
            "PlantFacility ": "275,000 sq ft",
            "CMO / CMDO": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "DG - SANCO / EMA (EU)": "Yes",
            "FDA (US)": "Yes",
            "HPFB-HC (CA)": "Yes",
            "Plant details": "Sterile Products facility offers:\r\n* Four sterile filling suites for quick change-overs and flexibility\r\n* Fully automated clean-in-place and sterilize-in place systems\r\n* Aseptic filling and terminal sterilization providing various manufacturing process capabilities\r\n* A robotic system on the ointment filling line that minimizes human intervention\r\n* High speed ophthalmic solution line\r\nLyophilization suite:\r\n* Integrated into our high speed filling line and robotic loading systems means accelerated freezing time, minimized product degradation and reduced risk of microbial contamination\r\n* Houses two BOC/Edwards lyophilizers with production capacity of 374 ft2 of freeze-drying shelf space (120 and 254 ft2)\r\n* Semi-automated inspection of vials for quality assurance\r\nNon-Sterile Products - Manufacturing facilities for non-sterile ointments, creams, gels and liquids\r\n* A two-story, gravity fed plant design facilitating the transfer from compounding to filling for ointments, gels, creams, lotions and solutions\r\n* Current volume capability ranges from 600-18,000 liters for liquids and 500-1,100kg for ointments and creams\r\n* 1,000 liter Giusti homogenizer\r\n* Laminate and plastic tubes",
            "Comment": "Operations include sterile and non-sterile processing, lyophilization, packaging and warehousing capabilities supported by an experienced quality team with on-site laboratories"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Jubilant Life Sciences",
            "Website": "www.jublhs.com",
            "Address": "3525, N. Regal, Spokane, WA, 99207",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "United States",
            "Phone": "+1 509 489 5656",
            "OperationStatus": "Operating",
            "LocationAlias": "Jubilant HollisterStier",
            "PlantFacility ": "190,000 sq ft",
            "LaboratoryR&D": "190,000ft2",
            "VolumeCapacityOverview": "2,100 ft2 production space",
            "CMO / CMDO": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "FDA (US)": "Yes",
            "HPFB-HC (CA)": "Yes",
            "MHRA (UK)": "Yes",
            "PMDA (JP)": "Yes",
            "Plant details": "* Designed for multi-product operations and houses 3 separate manufacturing areas that include two commercial high speed fill lines and a clinical trial area\r\n*  All filling lines are integrated into lyophilizers that range in size from 30 ft2 to 375 ft2.\r\n* Offers multiple options for compounding including aseptic compounding, portable compounding vessels and large fixed compounding tanks\r\n* Vial and inspection areas include visual inspection, labeling, Ink Jet coding and secondary packaging",
            "Comment": "Clinical to commercial sterile injectables, lyophilization"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubilantpharma.com",
            "Address": "56 Industrial Area, Nanjangud, Distt. Mysore, Nanjangud, Karnataka, 571302",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 8221 228 402-08",
            "OperationStatus": "Operating",
            "LocationAlias": "Karnataka, Jubilant Pharma Limited ",
            "API": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "ANVISA (BR)": "Yes",
            "AFSSAPS (FR)": "Yes",
            "COFEPRIS (MX)": "Yes",
            "FDA (US)": "Yes",
            "KFDA / MFDS (KR)": "Yes",
            "PMDA (JP)": "Yes",
            "TGA (AU)": "Yes",
            "Comment": "US FDA, PMDA Japan, KFDA Korean and COFEPRIS Mexico approved facility for Active Pharmaceutical Ingredients"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubilantpharma.com",
            "Address": "Sikandarpur Bhainswal, Bhagwanpur, Roorkee, Uttarakhand, 247661",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 1332 235 161-66",
            "OperationStatus": "Operating",
            "LocationAlias": "Uttarakhand, Jubilant Pharma Limited ",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "ANVISA (BR)": "Yes",
            "FDA (US)": "Yes",
            "MCC (ZA)": "Yes",
            "MHRA (UK)": "Yes",
            "PMDA (JP)": "Yes",
            "Comment": "US FDA, UKMHRA, PMDA Japan, ANVISA Brazil and MCC South Africa approved facility for Solid Dosage Formulations"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubl.com",
            "Address": "Block 133, Village Samlaya, Taluka Sav, Distt. Vadodara, Gujarat, 391520",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 2667 251 361, 251 563-4",
            "OperationStatus": "Operating",
            "LocationAlias": "Gujarat"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubl.com",
            "Address": "Plot No.5 Vilayat GIDC, Taluka Vagra, Bharuch, Gujarat, 392012",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 02641 - 281500 ( 30 Lines )",
            "OperationStatus": "Operating",
            "LocationAlias": "SEZ, Bharuch"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubl.com",
            "Address": "Bhartiagram Gajraula, Distt. Amroha, Uttar Pradesh, 244223",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 5924 252 353-60",
            "OperationStatus": "Operating",
            "LocationAlias": "Uttar Pradesh"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubl.com",
            "Address": "Village Nimbut, Rly. Stn. Nira, Distt. Pune, Maharashtra, 412102",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 2112 269 155-57",
            "OperationStatus": "Operating",
            "LocationAlias": "Maharashtra"
        },
        {
            "Rank": "39",
            "Company": "Jubilant Life Sciences",
            "Ownership": "Public: JUBILANT (NSE)",
            "Website": "www.jubl.com",
            "Address": "N-34, MIDC, Anand Nagar, Ambernath, Maharashtra, 421506",
            "Headquarters": "Uttar Pradesh, India",
            "Country": "India",
            "Phone": "+91 251 2620437-438",
            "OperationStatus": "Operating",
            "LocationAlias": "Maharashtra"
        },
        {
            "Rank": "40",
            "Company": "PT Kalbe",
            "Ownership": "Public: JKSE:KLBF",
            "Website": "www.kalbe.co.id",
            "Address": "Jl. Let. Jend. Suprapto Kav. 4, Cempaka Putih, Jakarta 10510, Indonesia",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Jakarta, Indonesia",
            "Country": "Indonesia",
            "Phone": "(62-21) 4287 3888",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Factory located at Cikarang, Bekasi 17550 Indonesia",
            "RegionalEntity": "Pharmaceutical subsidiaries\r\n*Kalbe Global \r\n*Kalbe Genexine Biologics\r\n*Innogene Kalbiotech\r\n*Kalbio Global Medika\r\n*Finusolprima Farma Internasional\r\n*Bifarma Adiluhung\r\n*Orange Kalbe Limited\r\n* Innolab Sains Internasional\r\n* Dankos Farma\r\n*Bintang Toedjoe\r\n*Hexpharm Jaya Laboratories \r\n*Saka Farma Laboratories \r\n*Pharma Metric Laboratories \r\n*Global Onkolab Farma \r\n*Kalbe Vision\r\n*Global Onkolab Farma\r\n\r\n",
            "EstimatedSales": "₹21,074,306 million (2018)",
            "EstimatedEmployees": "12,575 worldwide"
        },
        {
            "Rank": "42",
            "Company": "Alembic Pharmaceuticals",
            "Ownership": "Public: BSE:533573",
            "Website": "www.alembicpharmaceuticals.com",
            "Address": "Alembic Road, Vadodara - 390 003, Gujarat,INDIA",
            "NumberOfProducts": "International Generics : 161 ANDAs filings (89 approvals including 12 tentative)\r\nAPIs: 100 DMF applications, 185 brands",
            "Headquarters": "Gujarat, India",
            "Country": "India",
            "Phone": "+91 0265-2280550",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Nine (9 manufacturing facilities): 3 API & 6 formulation plants",
            "EstimatedSales": "₹3,934.68 crones",
            "EstimatedEmployees": "11,130"
        },
        {
            "Rank": "43",
            "Company": "Biocon",
            "Ownership": "Public: BSE: 532523 and NSE: BIOCON",
            "Website": "www.biocon.com",
            "Address": "20th KM, Hosur Road,\r\nElectronic City, Bangalore, India - 560 100",
            "NumberOfProducts": "7 Biologics including 2 Novels and 5 Biosimilars taken from Lab to Market\r\n",
            "Headquarters": "Bangalore, Karnataka, India",
            "Country": "India",
            "Phone": "+91 80 2808 2808 / 91 80 4014 4014",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Manufacturing locations in Bangalore, India, Malaysia, Hyderabad, India and Visakhaptnam, India",
            "RegionalEntity": "8 subsidiaries and 2 step down subsidiaries\r\nBiocon Pharma Limited (generics)\r\nSyngene International Limited (CRO)\r\nBiocon SA (generic recombinant human insulin and its analogues)\r\nBiocon SDN. BHD (manufacture recombinant human insulin )\r\nNeoBiocon FZ LLC (research and marketing pharmaceutical company)\r\nBiocon FZ -LLC (marketing entity)\r\nBiocon Biologics Limited (Houses Biocon’s biosimilar biologics business)\r\nBiocon Pharma Inc. (commercialization of generic formulations in the United States)",
            "EstimatedSales": "Revenue\r\n1237 In Rs. Crore (FY2018-2019)",
            "EstimatedEmployees": "9,000+",
            "Founded": "1978"
        },
        {
            "Rank": "44",
            "Company": "Strides Pharma Science Limited",
            "Ownership": "Public: 532531 (BSE)",
            "Website": "www.strides.com",
            "Address": "Strides House, Bilekahalli, Bannerghatta Road,\r\nBangalore – 560076, India",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Bangalore, India",
            "Country": "India",
            "Phone": "+91 80 6784 0000 / 6784 0738",
            "OperationStatus": "Operating",
            "LocationAlias": "Formerly Strides Shasun Limited",
            "NumberOfLocations": "Seven (7) India‐ Bangalore (two sites), Pondicherry, and Chennai, Singapore, Italy‐ Milan, and Kenya‐ Nairobi including 5 Generic pharma manufacturing locations\r\n",
            "RegionalEntity": "Strides has 43 subsidiaries",
            "EstimatedSales": "REVENUES (₹ MN) 28,576 (2017-2018)",
            "EstimatedEmployees": "1,001-5,000",
            "Founded": "1990"
        },
        {
            "Rank": "45",
            "Company": "Adcock Ingram",
            "Ownership": "Public: AIP (JSE)",
            "Website": "www.adcock.co.za",
            "Address": "1 New Road, (c/o New Road & 7th Street), Midrand, South Africa",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Midrand, South Africa",
            "Country": "South Africa",
            "Phone": "+27 11 635 0000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "High Volume Liquids Manufacture - Clayville\r\nTablet and Capsule (ARV) Manufacture - Wadeville\r\nSteriles and Critical Care Manufacture - Aeroton\r\nAdditional Manufacturing - Bangalore",
            "EstimatedSales": "7 089 058 (R’000) 2019",
            "EstimatedEmployees": "1,001-5,000",
            "Founded": "1890"
        },
        {
            "Rank": "46",
            "Company": "Eurofarma Laboratórios",
            "Ownership": "Private Company",
            "Website": "www.eurofarma.com.br",
            "Address": "Av. Councilman Jose Diniz, 3465 - Campo Belo, San Paulo, Brazil",
            "NumberOfProducts": "Covers 30 different specialties in 101 therapeutic classes. In Brazil, it offers 287 different molecules and more than 600 products",
            "Headquarters": "San Paulo, Brazil",
            "Country": "Brazil",
            "Phone": "+55 11 5090-8600",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Operations in 19 nations – Argentina, Bolivia, Chile, Colombia, Ecuador, Mexico, Mozambique, Paraguay, Peru, Uruguay, Venezuela, Guatemala and other countries in Central America and the Caribbean, such as Belize, Costa Rica, El Salvador, Honduras, Nicaragua, Panama and the Dominican Republic",
            "RegionalEntity": "Subsidiaries:\r\n* Momenta Farmacêutica\r\n* Magabi Pesquisas Clínicas e Farmacêuticas\r\n* Supera RX Medicamentos\r\n* Orygen",
            "EstimatedSales": "$823 million (2015)",
            "EstimatedEmployees": "6,700 employees, more than 5,600 of which are in Brazil"
        },
        {
            "Rank": "47",
            "Company": "Mayne Pharma Group Limited",
            "Ownership": "Public: ASX: MYX",
            "Website": "www.maynepharma.com",
            "Address": "1538 Main N Rd\r\nAdelaide SA 5106 Australia",
            "NumberOfProducts": "Product portfolio of 60+ molecules marketed in the US\r\n30+ pipeline products in the US of which 14 products pending approval at the FDA",
            "Headquarters": "Adelaide, Australia",
            "Country": "Australia",
            "Phone": "+61 8 8209 2666",
            "OperationStatus": "Operating",
            "LocationAlias": "Mayne Pharma",
            "NumberOfLocations": "Two (2) locations",
            "EstimatedSales": "A$525.2m (2019)",
            "EstimatedEmployees": "850+",
            "Founded": "1983"
        },
        {
            "Rank": "48",
            "Company": "Ipca Laboratories Ltd",
            "Ownership": "Public: IPCALAB (NSE)",
            "Website": "www.ipca.com",
            "Address": "48, Kandivli Industrial Estate, Kandivli (West)\r\nMumbai - 400 067, Maharashtra",
            "NumberOfProducts": "Over 350 formulations and 80 APIs for various therapeutic segments",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 (22) 6647 4444",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Fifteen (15) \"Works\" locations",
            "RegionalEntity": "Ipca Laboratories, UK\r\nIpca Pharma, Australia\r\nIpca Pharma, New Zealand\r\nIpca Pharma, Nigeria\r\nIpca Pharmaceuticals, USA\r\nPisgah Labs Inc, USA\r\nBayshore Pharmaceuticals Inc, USA\r\nIpca Pharmaceuticals Limited S.A DE C.V\r\nOnyx Scientific Limited, UK\r\nTonira Exports Limited, India",
            "EstimatedSales": " ₹ 3687.74 Crs / US$ 526 Mn (2019)",
            "EstimatedEmployees": "13,703",
            "Founded": "1949"
        },
        {
            "Rank": "49",
            "Company": "Natco Pharma",
            "Ownership": "Public: NATCOPHARM (NSE)",
            "Website": "www.natcopharma.co.in",
            "Address": "Natco House\r\nRoad No.2, Banjara Hills\r\nHyderabad-500 034, India",
            "NumberOfProducts": "Nexavar\r\r\nTykerb\r\r\nRevlimid\r\r\nAfinitor\r\r\nZytiga\r\r\nAubagio\r\r\nTarceva\r\r\nKyprolis\r\r\nEliquis\r\r\nPomalyst\r\r\nSovaldi\r\r\nIbruvica\r\r\n\r\nOver 50 active pharmaceutical ingredients (“APIs”)",
            "Headquarters": "Hyderabad. India",
            "Country": "India",
            "Phone": "+91-40-2354 7532\r\n+91-40-2354 5298/23548243",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Seven (7) manufacturing locations in India: five formulation locations across India – two in Dehradun (Uttarakhand), one in Kothur (Mahboobnagar, Telangana), one in Nagarjuna Sagar (Nalgonda Dist, Telangana), and one in Guwahati (Assam); two chemicals manufacturing locations – one in Mekaguda (Mehboobnagar, Telangana), and another in Manali (Chennai)",
            "RegionalEntity": "Natco Pharma Inc.\r\nTime Cap Overseas Lmited Inc\r\nNatco Pharma Asia\r\nNatco Pharma (Canada)\r\nNatco Pharma Australia\r\nNatco Lifesciences Philippines",
            "EstimatedSales": " ₹ 22,247 million (2019)",
            "EstimatedEmployees": "2,500+",
            "Founded": "1981"
        },
        {
            "Rank": "50",
            "Company": "Genomma",
            "Ownership": "Public: BMV:LAB B",
            "Website": "https://genommalab.com",
            "Address": "Samara Building\r\nAntonio Dovalí Jaime #70, 2nd Floor\r\nCol. Santa Fe. Del. Álvaro Obregón.\r\nMéxico, D.F. CP 01210",
            "NumberOfProducts": "40+ brands of OTC and PC",
            "Headquarters": "México, D.F. CP",
            "Country": "Mexico",
            "Phone": "+52 (55) 50810000",
            "OperationStatus": "Operating",
            "LocationAlias": "Genomma Lab Internacional S.A.B. de C.V ",
            "NumberOfLocations": "One (1) manufacturing in Toluca, State of Mexico",
            "EstimatedSales": "$11,921 (MXN mm) (2018)\r\n\r\n",
            "EstimatedEmployees": "1,000+"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "150 Signet Drive, Toronto, Ontario M9L 1T9",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "(800) 268-4623",
            "OperationStatus": "Operating",
            "LocationAlias": "Signet Campus",
            "RegionalEntity": "Apotex Inc., focused on generics\r\nApobiologix, a division of Apotex Inc. - biosimilar development\r\nApoPharma, discovery and development of innovative medicines\r\nAveva, an affiliate of Apotex Inc. -  transdermal solutions.\r\nApotex Consumer Products, -  brand name products\r\nGlobal Active Pharmaceutical Ingredients (GAPI), a division of Apotex Inc. focused on the manufacture of APIs for Apotex and third parties",
            "EstimatedEmployees": "5,000+",
            "Founded": "1974",
            "PlantFacility ": "Ten buildings situated within a four block radius",
            "VolumeCapacityOverview": "produce and package in excess of 750 million dosages a month",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Global HQ": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "50 Steinway Blvd., Etobicoke, Ontario, M9W 6Y3",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "416-675-0338",
            "OperationStatus": "Operating",
            "LocationAlias": "Etobicoke",
            "Warehouse": "Stores 15,000 pallets @ 75 ft.",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Other": "Yes",
            "Mfg.": "Yes",
            "Oral solid dose overall": "Yes",
            "Tablets": "Yes",
            "Pellets": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "380 Elgin Mills Rd E, Richmond Hill, ON L4C 5H2",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "905-884-2050",
            "OperationStatus": "Operating",
            "LocationAlias": "Richmond Hill",
            "VolumeCapacityOverview": "Operating at aFacility Production Limit of up to 28 million bottles of liquid pharmaceuticals per year",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Ophthalmics / (Eye Drops / Gels / Suspension, etc.)": "Yes",
            "Liquids (non-injectables)": "Yes",
            "Oral solutions": "Yes",
            "Sprays": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www.apotexpharmachem.com",
            "Address": "11, 34, 50 Spalding Drive\r\nBrantford, Ontario, N3T 6B8",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "519-756-8942",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Pharmachem",
            "VolumeCapacityOverview": "Facility Production\r\nLimit of up to 75 tonnes of final products per year",
            "API": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www.apotexpharmachem.com",
            "Address": "40 Scurfield Boulevard, Winnipeg, Manitoba, R3Y 1G4",
            "NumberOfProducts": "Large-scale operations can handle up to 102,000 litres of fermented products",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "204-989-6830",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Fermentation",
            "API": "Yes",
            "Biosimilars / Biologicals": "Yes",
            "CMO / CMDO": "Yes",
            "Mfg.": "Yes",
            "Bioreactor": "YES",
            "Bioreactor volume": "1500L Pilot Scale\r\n14,000L x3 Production Scale\r\n30,000L x 2 Production Line",
            "Plant details": "*Process optimization and scale-up services are carried out in 20 litre, 200 litre, and 1500 litre fermentation suites and chemical pilot plants\r\n*Its large-scale operations can handle up to 102,000 litres of fermented products, and are housed in isolation and purification plants"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "20 Kenhar Street, Toronto, Ontario, M9L 1N1",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "(416) 749-9300",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Inc.",
            "VolumeCapacityOverview": "Operating at maximum production rates as follows:\r\nactive ingredients = 43.33 kilograms per hour;\r\ninactive ingredients = 120 kilograms per hour; and\r\nsugar = 12 kilograms per hour",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "285 Garyray Drive, Toronto, Ontario, M9L 1P3",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "905-884-7412",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "3701 Weston Road, Toronto, Ontario, M9L 2S8",
            "NumberOfProducts": "Facility Production\r\nLimit of up to 410,000,000 dosages of products per year",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "(416) 749-9300",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Inc.",
            "VolumeCapacityOverview": "Antibiotics",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Mfg.": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "400 Ormont Drive, Toronto, Ontario, M9L 1N9",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "416-749-9300",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "4100 Weston Road, Toronto, Ontario, M9L 2Y6",
            "Headquarters": "Ontario, Canada",
            "Country": "Canada",
            "Phone": "(877) 427-6839",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Inc.",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www.apotexpharmachem.com",
            "Address": "Plot No. 1A, Bommasandra Industrial Area, 4th Phase, Bommasandra Industrial Estate (Post Office), Bangalore, Karnataka, 560 099",
            "NumberOfProducts": "Six work centers, can handle six different active pharmaceutical ingredients simultaneously",
            "Headquarters": "Ontario, Canada",
            "Country": "India",
            "Phone": "+91-80-228-910-00",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Pharmachem India Pvt. Ltd.",
            "VolumeCapacityOverview": "Operating volume capacity of 25 litres to 3000 litres and a total installed capacity of 31000 litres",
            "API": "Yes",
            "Mfg.": "Yes",
            "Plant details": "1. Kilo lab: Two sets with three reactors each.\r\n* Kilo lab 1: Dedicated facility for handling class III products.\r\n* Kilo lab 2: For handling high value, low volume APIs.\r\n2. Production blocks\r\n* Production block 1: Equipped with 12 reactors of capacity ranging 250 L to 1000 L.\r\n* Production block 2: Equipped with 14 reactors of capacity ranging 500 L to 3000 L.\r\nPlant Capabilities\r\n* Standard Operating Temperature Range: - 15 °C to 140 °C\r\n* High pressure/high vacuum operating ranges\r\n* Low & High Temperatures Capability from: –80 °C to 150 °C\r\n* High containment procedures for potent APIs\r\nSolvent recovery and recycling\r\n* APIPL drying and material handling areas are built to class 100,000 clean room specifications. Three product drying technologies are currently in use: vacuum tray, vacuum rotary cone and fluid bed. Other special novel polymorph control equipment such as freeze drier and spray drier are used.\r\nAt APIPL, different size reduction techniques are being followed using equipment such as multi mill, colloidal mill, micronization and jet milling in order to achieve customer’s particle size requirements."
        },
        {
            "Rank": "51",
            "Company": "Apotex",
            "Ownership": "Private Company",
            "Website": "www1.apotex.com",
            "Address": "Plot No.1 And 2, Bommasandra Industrial Area, 4th Phase, Jigani Link Road, Bangalore, Karnataka, 560099, India",
            "Headquarters": "Ontario, Canada",
            "Country": "India",
            "Phone": "+91 80 2289 1014",
            "OperationStatus": "Operating",
            "LocationAlias": "Apotex Research Private Limited",
            "Finished Dose Form (FDF) / Generic": "Yes"
        },
        {
            "Rank": "*",
            "Company": "EMS Pharma",
            "Ownership": "Private Company",
            "Website": "www.ems.com.br",
            "Address": "Rod. Journalist Francisco Aguirre Proença, KM 08, Neighborhood Chacara Assay - Postcode 13186-901 - Hortolândia / SP",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Hortolândia, Brazil",
            "Country": "Brazil",
            "Phone": "55-19-3887-9800",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Six industrial plants based in São Bernardo do Campo, Hortolândia and Jaguariúna, in the state of São Paulo, Manaus, Brasília and Belgrade in Serbia",
            "EstimatedSales": "$4,200 million (2015)",
            "EstimatedEmployees": "5,000 throughout Brazil"
        },
        {
            "Rank": "*",
            "Company": "Abbott Laboratories",
            "Ownership": "Public: NYSE:ABT",
            "Website": "www.abbott.com",
            "Address": "An Illinois Corporation\t \r\n100 Abbott Park Road\r\nAbbott Park, Illinois 60064-6400",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Abbott Park, IL",
            "Country": "United States",
            "Phone": "(224) 667-6100",
            "OperationStatus": "Operating",
            "NumberOfLocations": "94 Worldwide locations\r\nCardiovascular and Neuromodulation Products (25 locations)\t \r\nDiagnostic Products (23 locations)\r\nEstablished Pharmaceutical Products (30 locations)\r\nNutritional Products (14 locations)\r\nNon-Reportable locations = 2",
            "EstimatedSales": "$30,578 million (2018)",
            "EstimatedEmployees": "103,000"
        },
        {
            "Rank": "*",
            "Company": "GSK",
            "Ownership": "Public: NYSE: GSK ",
            "Website": "www.gsk.com",
            "Address": "980 Great West Road, Brentford, TW8 9GS, England",
            "NumberOfProducts": "Partners with NGOs and generic manufacturers to manufacture and supply its products to developing countries\r\nProduct summary tbd",
            "Headquarters": "Middlesex, England",
            "Country": "United Kingdom",
            "Phone": "+44 20 8047 5000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Network of manufacturing sites and R&D centres in 36 countries and major R&D centres in the UK, USA, Spain, Belgium and China\r\n* Vaccines: 13 manufacturing sites, across 10 countries\r\nIn 2016 it reported 87 manufacturing sites across its pharmaceuticals, vaccines and consumer healthcare businesse",
            "EstimatedSales": "£30,821 million (2018)",
            "EstimatedEmployees": "95,490"
        },
        {
            "Rank": "*",
            "Company": "R-Pharm",
            "Ownership": "Private Company",
            "Website": "www.r-pharm.com",
            "Address": "119421, Moscow, Lenynskiy prospect, d. 111Б",
            "NumberOfProducts": "To be determined",
            "Headquarters": "Moscow, Russia",
            "Country": "Russia",
            "Phone": "+7 (495) 956 79 37",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Six (6) plants in Russia, Germany, Hungary, with a new location in Azerbaijan",
            "EstimatedSales": "$1,500 million (2015)",
            "EstimatedEmployees": "3,000+"
        },
        {
            "Rank": "*",
            "Company": "Insud Pharma",
            "Ownership": "Private Company",
            "Website": "www.insudpharma.com",
            "Address": "Paraguay 1535, C1061 ABC, Buenos Aires, Argentina",
            "NumberOfProducts": "Chemo subsidiary produces 100 molecules (steroids, hormones, prostaglandins, prazols and antibiotics), over 50 formulations with more than 200 different product presentations",
            "Headquarters": "Buenos Aires, Argentina",
            "Country": "Argentina",
            "Phone": "+54 11 4872-1200",
            "OperationStatus": "Operating",
            "LocationAlias": "Grupo Insud\r\nInsud Pharma",
            "NumberOfLocations": "Fifteen (15) industrial plants, 10 R&D centers",
            "RegionalEntity": "Chemo (APIs, FDF)\r\nExEltis\r\nmaBscience",
            "EstimatedSales": "Chemo estimated sales $1,100 milllion (2015)",
            "EstimatedEmployees": "6,000 worldwide"
        },
        {
            "Rank": "*",
            "Company": "Grupo Bago",
            "Ownership": "Private Company ",
            "Website": "www.bago.com.ar",
            "Address": "Bernardo de Irigoyen 248\r\n(C1072AAF) Capital Federal",
            "NumberOfProducts": "Over 480 products comprising 46 therapeutic lines",
            "Headquarters": "Buenos Aires, Argentina",
            "Country": "Argentina",
            "Phone": "(54-11) 4344-2000",
            "OperationStatus": "Operating",
            "LocationAlias": "Groupo Bago",
            "NumberOfLocations": "Laboratorios Bagó - Eleven (11) pharmaceutical production facilities worldwide. Industrial plants, strategically distributed among Argentina, Bolivia, Brazil, Chile, Mexico, Pakistan and Uruguay\r\nGrupo Bago: 13 Pharmaceutical and biological plants",
            "RegionalEntity": "Biofarmacéutica\r\n Laboratorios Bagó Argentina\r\n Química Montpellier (Argentina)\r\n Nutricia - Bagó (Argentina)\r\n Laboratorios Bioprofarma-Bagó (Arg.)\r\n Synthon Bagó (Arg.)\r\n Sinergium Biotech (Arg.)\r\n Laboratorios Bagó Bolivia\r\n Laboratorios Bagó Brasil\r\n Laboratorios Bagó Chile\r\n Laboratorios Bagó Colombia\r\n Laboratorios Bagó Costa Rica\r\n Laboratorios Bagó Cuba\r\n Laboratorios Bagó Ecuador\r\n Laboratorios Bagó El Salvador\r\n Laboratorios Bagó Guatemala\r\n Laboratorios Bagó Honduras\r\n Armstrong Laboratorios de México\r\n Laboratorios Bagó Nicaragua\r\n Laboratorios BF Biosciences Pakistán\r\n Laboratorios Bagó Perú\r\n Laboratorios Bagó República Dominicana\r\n Laboratorios Bagó Sri Lanka\r\n Laboratorios Gramón-Bagó de Uruguay",
            "EstimatedSales": "$1,100 million (2015)",
            "EstimatedEmployees": "+7,000"
        },
        {
            "Rank": "*",
            "Company": "Roemmers",
            "Ownership": "Private Company",
            "Website": "www.roemmers.com.ar",
            "Address": "Fray Justo Sarmiento 2350, B1636AKJ, Olivos, Buenos Aires, Argentina",
            "NumberOfProducts": "Roemmers markets 57 million units in Argentina alone on an annual basis\r\nTotal summary to be determined",
            "Headquarters": "Buenos Aires, Argentina",
            "Country": "Argentina",
            "Phone": "(5411) 4346-9700",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Operations in Brazil, Uruguay and Mexico",
            "EstimatedSales": "$1,050 million (2015)",
            "EstimatedEmployees": "1,001-5,000"
        },
        {
            "Rank": "*",
            "Company": "Polpharma",
            "Ownership": "Private Company",
            "Website": "www.polpharma.pl",
            "Address": "Pelplińska 19\r\n83-200 Starogard Gdański",
            "NumberOfProducts": "600 products, and another 200 are in the development phase",
            "Headquarters": "Starogard Gdański, Poland",
            "Country": "Poland",
            "Phone": "48 58 563 16 00",
            "OperationStatus": "Operating",
            "NumberOfLocations": "7 production plants in Poland, Russia and Kazakhstan, and 7 research and development centers",
            "RegionalEntity": "Polpharma SA Pharmaceutical Plant \r\nPolfa Warszawa SA \r\nMedana Pharma SA\r\nSanto Member of Polpharma Group\r\nAkrihin",
            "EstimatedSales": "$1,000 million (2015)",
            "EstimatedEmployees": "Over 7,500"
        },
        {
            "Rank": "*",
            "Company": "Prasco",
            "Ownership": "Private Company",
            "Website": "https://prasco.com",
            "Address": "6125 Commerce Court, Mason, Ohio 45040",
            "NumberOfProducts": "Has launched over 90 Authorized Generics",
            "Headquarters": "Mason, OH",
            "Country": "United States",
            "Phone": "513.618.3333",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Single location",
            "EstimatedSales": "$660 million (2015)",
            "EstimatedEmployees": "51-200"
        },
        {
            "Rank": "*",
            "Company": "Pharmascience",
            "Ownership": "Private Company",
            "Website": "www.pharmascience.com",
            "Address": "6111 Royalmount Avenue, Montreal (Qc) H4P 2T4, Canada",
            "NumberOfProducts": "The company commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products",
            "Headquarters": "Montreal, Canada",
            "Country": "Canada",
            "Phone": "514-340-9735",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Hybrid manufacturing strategy, with some products produced at Pharmascience's own facilities, and others manufactured through supply agreements with preferred suppliers\r\nProduction locations: Montreal, Canada",
            "EstimatedSales": "$750 million (2015)",
            "EstimatedEmployees": "1,500"
        },
        {
            "Rank": "*",
            "Company": "Unilab",
            "Ownership": "Private Company",
            "Website": "www.unilab.com.ph",
            "Address": "66 United St., Mandaluyong City, Philippines",
            "NumberOfProducts": "350 brands",
            "Headquarters": "Mandaluyong City, Philippines",
            "Country": "Philippines",
            "Phone": "(+632) 8-864522-1",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Six (6) production facilities\r\nUnilab, Inc. Manufacturing – solids products\r\nAsian Antibiotics, Inc. – penicillin, cephalosphorin and steroid products, Certified to ISO9001, ISO1400 and OHSAS18001\r\nAmherst Laboratories, Inc. – solids and liquids plants, EU-GMP Certified and PIC/s Compliant (Singapore, Malaysia and Austria)\r\nAmherst Parenterals, Inc. – small volume parenterals, large volume parenterals\r\nPhilippine Health Food Manufacturing – nutritionals\r\nBelmont Softgel Pharma Corporation – softgel capsules",
            "RegionalEntity": "Six (6) production facilities\r\nUnilab, Inc. Manufacturing – solids products\r\nAsian Antibiotics, Inc. – penicillin, cephalosphorin and steroid products, Certified to ISO9001, ISO1400 and OHSAS18001\r\nAmherst Laboratories, Inc. – solids and liquids plants, EU-GMP Certified and PIC/s Compliant (Singapore, Malaysia and Austria)\r\nAmherst Parenterals, Inc. – small volume parenterals, large volume parenterals\r\nPhilippine Health Food Manufacturing – nutritionals\r\nBelmont Softgel Pharma Corporation – softgel capsules",
            "EstimatedSales": "$835 million (2015)",
            "EstimatedEmployees": "6,000"
        },
        {
            "Rank": "*",
            "Company": "Pharmstandard",
            "Ownership": "Private Company",
            "Website": "https://pharmstd.com",
            "Address": "5B, Likhachyovsky Proezd, Dolgoprudny, Moscow Region, 141701, Russia",
            "NumberOfProducts": "330 pharmaceutical products\r\nOver 60 new products\r\nOver 140 esssential drugs",
            "Headquarters": "Dolgoprudny, Moscow",
            "Country": "Russia",
            "Phone": "+7 (495) 970 0030/32",
            "OperationStatus": "Operating",
            "LocationAlias": "Фармстандарт",
            "NumberOfLocations": "Five (5) factories",
            "RegionalEntity": "Phs-Leksredstva JSC (Kursk),\r\nPharmstandard-UfaVITA JSC (Ufa),\r\nPHS-Tomskhimpharm JSC (Tomsk),\r\nLekko CJSC (Volginsky settlement, Vladimir Region),\r\nJ.S.C. Biomed- Mechnikov (Moscow, Moscow Region),",
            "EstimatedSales": "$625 million (2015)",
            "EstimatedEmployees": "6,450"
        },
        {
            "Rank": "*",
            "Company": "Tecnoquimicas",
            "Ownership": "Private Company",
            "Website": "www.tqconfiable.com",
            "Address": "Cl. 23 #7-34, Cali, Valle del Cauca, Colombia",
            "NumberOfProducts": "Tecnoquímicas participates in 10 different markets and manufactures more than 4,000 references",
            "Headquarters": "Valle del Cauca, Colombia",
            "Country": "Colombia",
            "Phone": "+57 2 8825555",
            "OperationStatus": "Operating",
            "LocationAlias": "Tecnoquimicas",
            "NumberOfLocations": "30 productive areas in 8 plants in Colombia. Internationally, the company has 3 plants in Central America",
            "EstimatedSales": "$603 million (2015)",
            "EstimatedEmployees": "3,379"
        },
        {
            "Rank": "*",
            "Company": "Megalabs",
            "Ownership": "Private Company",
            "Website": "www.megapharma.com",
            "Address": "Parque de las Ciencias, Route 101, Km 23.500, Mega Pharma Building, 3rd Floor, 14000 Canelones, Uruguay",
            "Headquarters": "Canelones, Uruguay",
            "Country": "Uruguay",
            "Phone": "+(598) 2683 8000",
            "OperationStatus": "Operating",
            "LocationAlias": "Formerly Mega Pharma",
            "NumberOfLocations": "Mega Campus /  Parque de las Ciencias (Science Park)",
            "EstimatedSales": "Not available",
            "EstimatedEmployees": "5,001-10,000"
        },
        {
            "Rank": "*",
            "Company": "Mankind Pharma",
            "Ownership": "Private Company",
            "Website": "www.mankindpharma.com/",
            "Address": "208, Okhla Industrial Estate Phase 3 Rd, Okhla Phase III, Okhla Industrial Area, New Delhi, Delhi 110020",
            "NumberOfProducts": "Prescription medications: 1000+ products, 22 dosage forms, 17 therapeutic areas",
            "Headquarters": "Delhi, India",
            "Country": "India",
            "Phone": "+91-11-46541111",
            "OperationStatus": "Operating",
            "NumberOfLocations": "12 manufacturing units, 21 manufacturing facilities in various areas like Paonta Sahib, Himachal Pradesh, Sikkim, Vizag & Rajasthan",
            "EstimatedSales": "$525 million (2015)",
            "EstimatedEmployees": "14,000+"
        },
        {
            "Rank": "*",
            "Company": "Ajanta Pharma",
            "Ownership": "Public: BSE:532331",
            "Website": "www.ajantapharma.com",
            "Address": "Ajanta House, Charkop, Kandivli West, Mumbai 400 067 India",
            "NumberOfProducts": "150+Products",
            "Headquarters": "Mumbai, India",
            "Country": "India",
            "Phone": "+91 22 6606 1000",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Seven (7) manufacturing facilities in India and Mauritius. 2 of the facilities in India have been successfully approved by US FDA",
            "EstimatedSales": "₹2,055 cr. (2018)",
            "EstimatedEmployees": "6,500"
        },
        {
            "Rank": "*",
            "Company": "Adare Pharmaceuticals",
            "Ownership": "Private ",
            "Website": "www.adarepharma.com",
            "Address": "Princeton Pike Corporate Center\r\n1200 Lenox Drive, Suite 100\r\nLawrenceville, NJ 08648",
            "NumberOfProducts": "40+ Rx and OTC ",
            "Headquarters": "Lawrenceville, NJ",
            "Country": "United States",
            "Phone": "(609) 450-1312",
            "OperationStatus": "Operating",
            "EstimatedEmployees": "501-1,000",
            "VolumeCapacityOverview": "100+ billion doses per year",
            "API": "Yes",
            "CMO / CMDO": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Global HQ": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Coacervation": "Yes",
            "Powders": "Yes",
            "Liquids (non-injectables)": "Liquid to solid suspension",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes",
            "Taste Masking & ODTs": "Yes"
        },
        {
            "Rank": "*",
            "Company": "Antibiotice SA",
            "Ownership": "Public",
            "Website": "www.antibiotice.ro",
            "Address": "1 Valea Lupului Street, lasi 707410, Romania",
            "NumberOfProducts": "Generic drugs for human use (157 products)",
            "Headquarters": "Lasi, Romania",
            "Country": "Romania",
            "Phone": "+40 232 209 000",
            "OperationStatus": "Operating",
            "LocationAlias": "Antibiotice SA",
            "EstimatedSales": "36 4.576.466 lei (2018) / ~$84,344,765.41 USD",
            "API": "Yes",
            "# of products": "Produced by biosynthesis",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Global HQ": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Liquids (non-injectables)": "Powders",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "Other": "Suppositories, pessaries",
            "cGMP ": "Yes",
            "EU-GMP (EU)": "Yes",
            "FDA (US)": "Yes"
        },
        {
            "Rank": "*",
            "Company": "Apicore",
            "Ownership": "Mylan",
            "Website": "www.apicore.com",
            "Address": "49 Napoleon Court\r\nSomerset, NJ - 08873",
            "NumberOfProducts": "Manufactures over 100 different API's",
            "Headquarters": "Somerset, NJ",
            "Country": "United States",
            "Phone": "(732) 748 - 8882",
            "OperationStatus": "Operating",
            "LocationAlias": "Apicore US LLC.",
            "EstimatedEmployees": "51-200",
            "VolumeCapacityOverview": "Installed capacity of 60 tons / annum",
            "API": "Liquid",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Global HQ": "Yes",
            "Labs / R&D / Technology Center": "Yes",
            "Mfg.": "Yes",
            "Ophthalmics / (Eye Drops / Gels / Suspension, etc.)": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Powders": "Yes",
            "Liquids (non-injectables)": "Suspension",
            "Oral solid dose overall": "Yes",
            "Tablets": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "Other": "Films",
            "cGMP ": "Yes",
            "FDA (US)": "Yes",
            "Plant details": "3 Multi-purpose manufacturing suites with batch sizes of 20-300kg\r\nReactors from 10Lit - 4,000 Lit volume\r\nTotal volume of 25,000 Lit with combination of 60% MSGL & 40% SS reactors\r\nChemical area with 5 micron filtered air\r\n3 Multi-purpose crystallizer area of class ISO 8\r\nDry poweder processing of class ISO 8 with different particle size reduction and blending equipment\r\nHigh potent manufacturing suite to handle Cytotoxic molecules of BAND 4& 5"
        },
        {
            "Rank": "*",
            "Company": "Bayer PharmaChemcials",
            "Ownership": "Unit of Bayer AG (Public)",
            "Website": "https://pharmachemicals.bayer.com",
            "Address": "Müllerstrasse 178 D-13353 Berlin",
            "Headquarters": "Berlin, Germany",
            "Country": "Germany",
            "Phone": "+49 30 4681111",
            "OperationStatus": "Operating",
            "API": "Yes",
            "Regional HQ": "Yes"
        },
        {
            "Rank": "*",
            "Company": "Biem",
            "Ownership": "Private",
            "Website": "www.biemilac.com",
            "Address": "Turgut Reis Cad. No:21 Tandoğan / Ankara",
            "Headquarters": "Ankara, Turkey",
            "Country": "Turkey",
            "Phone": "+90 312 230 29 29",
            "OperationStatus": "Operating",
            "EstimatedEmployees": "49",
            "Global HQ": "Yes",
            "Mfg.": "No",
            "Ophthalmics / (Eye Drops / Gels / Suspension, etc.)": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Ampoules": "Yes",
            "Vials": "Yes",
            "Powders": "Lyophilized for infusions",
            "Capsules": "Yes",
            "Topicals (Creams, Ointments and Gels)": "Yes",
            "Sprays": "Yes"
        },
        {
            "Rank": "*",
            "Company": "Biocad",
            "Ownership": "Private",
            "Website": "www.biocadglobal.com",
            "Address": "34-A, ukl. Svyazi, Strelna, St. Petersburg, 198515",
            "NumberOfProducts": "58 medicinal products, 21 of which are biological, 40 in development",
            "Headquarters": "St. Petersburg, Russia",
            "Country": "Russia",
            "Phone": "+7 (812) 380-49-33",
            "OperationStatus": "Operating",
            "EstimatedSales": "€230 million euros (2017)",
            "EstimatedEmployees": "2,200 \r\n(420 R&D)",
            "API": "Yes",
            "Biosimilars / Biologicals": "Yes",
            "cGMP ": "Yes"
        },
        {
            "Rank": "*",
            "Company": "Moehs Iberica S.L.",
            "Ownership": "Subsidiary of PMC Global Inc. (Private)",
            "Website": "www.moehs.com",
            "Address": "Pol. Ind. Cova Solera, C/Roma 8-12, Rubi (Barcelona), 08191",
            "Country": "Spain",
            "Phone": "+34 93 586 05 20",
            "OperationStatus": "Operating",
            "LocationAlias": "Moehs Iberica S.L.",
            "EstimatedEmployees": "68",
            "Global HQ": "Yes",
            "Comment": "Currently, MOEHS IBERICA is an independent profit center within PMC managing manufacturing sites of MOEHS Group"
        },
        {
            "Rank": "*",
            "Company": "Alvogen",
            "Ownership": "Private",
            "Website": "https://alvogen.com",
            "Address": "44 Whippany Road, Suite 300\r\nMorristown, NJ 07960",
            "NumberOfProducts": "200+ generic projects in pipeline\r\n75 pipeline ANDA's\r\n350 marketed products",
            "Headquarters": "Morristown, NJ",
            "Country": "United States",
            "Phone": "973.796.3400",
            "OperationStatus": "Operating",
            "NumberOfLocations": "Five (5)+L43 manufacturing and development hubs in the U.S., Romania, Korea and Taiwan",
            "EstimatedSales": "1.1 billion USD (2017)",
            "EstimatedEmployees": "2,800",
            "Biosimilars / Biologicals": "Yes",
            "Finished Dose Form (FDF) / Generic": "Yes",
            "Global HQ": "Yes",
            "Injectables (Parenterals, Liquid, Lyophilized, etc.)": "Yes",
            "Vials": "Yes",
            "Oral solutions": "Yes",
            "Oral solid dose overall": "Yes",
            "Capsules": "Yes",
            "Tablets": "Yes",
            "Transdermal patches": "Yes"
        },
        {
            "Rank": "BI top 103",
            "Company": "Nectar Lifesciences",
            "Website": "www.neclife.com",
            "Address": "Sco 38-39, Sector 9d\r\nChandigarh 160009 India",
            "Headquarters": "Chandigarh, India",
            "Country": "India",
            "Phone": "+91172-3047777",
            "OperationStatus": "Operating"
        },
        {
            "Rank": "BI top 103",
            "Company": "Lincoln Pharmaceuticals Limited",
            "Website": "www.lincolnpharma.com",
            "Address": "B/H. Satyam Complex\r\nAhmedabad 380 062 India",
            "Headquarters": "Ahmedabad, India",
            "Country": "India",
            "Phone": "+91-79-41078000"
        },
        {
            "Rank": "BI top 103",
            "Company": "FDC Limited",
            "Website": "www.fdcindia.com",
            "Address": "142-48, Swami Vivekananda Rd\r\nMumbai, Maharashtra 400102 India",
            "Country": "India",
            "Phone": "91-022 -30719100-399"
        },
        {
            "Rank": "BI top 103",
            "Company": "Panacea Biotec Ltd",
            "Website": "www.panacea-biotec.com",
            "Address": "B-1 Extn./ G-3, Mohan Co-Op. Industrial Estate\r\nNew Delhi 110044 India",
            "Country": "India",
            "Phone": "+91-11-41679000"
        },
        {
            "Rank": "BI top 103",
            "Company": "RPG Life Sciences Limited",
            "Website": "www.rpglifesciences.com",
            "Address": "463 4th Fl Rpg House\r\nMumbai\r\n400 030\r\nIndia",
            "Country": "India",
            "Phone": "91.22.6660.6375"
        },
        {
            "Rank": "BI top 103",
            "Company": "Jagsonpal Pharmaceuticals",
            "Website": "www.jagsonpal.com",
            "Address": "T-210 J, Shahpur Jat\r\nNew Delhi\r\n110 049\r\nIndia",
            "Country": "India",
            "Phone": "91 11 2649 4519"
        },
        {
            "Rank": "BI top 103",
            "Company": "Unichem Laboratories Ltd.",
            "Website": "www.unichemlabs.com",
            "Address": "Unichem Bhavan, Prabhat Estate, Off. S. V. Rd\r\nMumbai  400 102 India",
            "Country": "India",
            "Phone": "+91 022 66 888 333"
        },
        {
            "Rank": "BI top 103",
            "Company": "Marksans Pharma Ltd\r\n",
            "Website": "www.marksanspharma.com",
            "Address": "11th Fl Grandeur Off Veera Desai Rd\r\nMumbai\r\n400 053\r\nIndia\r\n",
            "Country": "India\r\n",
            "Phone": "+ 91 (22) 4001-20-00\r\n"
        },
        {
            "Rank": "BI top 103",
            "Company": "Orchid Pharma Ltd.\r\n\r\n\r\n",
            "Website": "www.orchidpharma.com",
            "Address": "Orchid Towers, #313, Valluvar Kottam High Rd\r\nChennai\r\n600 034\r\nIndia",
            "Country": "India",
            "Phone": "91-44-28211000"
        },
        {
            "Rank": "BI top 103",
            "Company": "Alcon, Inc.",
            "Website": "www.alcon.com",
            "Address": "Chemin De Blandonnet 8\r\nGeneva\r\n1214\r\nSwitzerland",
            "Country": "Switzerland",
            "Phone": "+41 58 911 20 00\r\n"
        },
        {
            "Rank": "BI top 103",
            "Company": "ANI Pharmaceuticals,",
            "Website": "www.anipharmaceuticals.com",
            "Address": "210 Main St W\r\nBaudette MN 56623 USA",
            "Country": "United States",
            "Phone": "218.634.3500"
        },
        {
            "Rank": "BI top 103",
            "Company": "Jenburkt Pharmaceuticals ",
            "Website": "www.jenburkt.com",
            "Address": "Nirmala Apts, 93, Jayprakash Rd\r\nMumbai\r\n400 058 India",
            "Country": "India",
            "Phone": "+91 22 67603603"
        },
        {
            "Rank": "BI top 103",
            "Company": "Laboratorios Farmaceuticos ROVI SA",
            "Website": "www.rovi.es",
            "Address": "Calle Jose Isbert\r\nMadrid 28223 Spain",
            "Country": "Spain",
            "Phone": " +(34) 91 021 30 00"
        },
        {
            "Rank": "BI top 103",
            "Company": "Teligent, Inc.\r\n\r\n",
            "Website": "www.teligent.com",
            "Address": "105 Lincoln Ave\r\nBuena NJ 08310 USA",
            "Country": "United States",
            "Phone": "856.697.1441"
        },
        {
            "Rank": "BI top 103",
            "Company": "Biofarm S.A.",
            "Website": "www.biofarm.ro",
            "Address": "99 Logofatul Tautu St\r\nBucharest\r\n031212\r\nRomania",
            "Country": "Romania",
            "Phone": "+40 21 301 06 00"
        },
        {
            "Rank": "BI top 103",
            "Company": "Themis Medicare",
            "Website": "www.themismedicare.com",
            "Address": "11/12, Udyog Nagar\r\nMumbai 400104 India",
            "Country": "India",
            "Phone": "+91 22 67607080\r\n"
        },
        {
            "Rank": "BI top 103",
            "Company": "Faes Farma, S.A.\r\n",
            "Website": "www.faes.es",
            "Address": "Avenida Autonomia\r\nLeioa 48940 Spain",
            "Country": "Spain"
        },
        {
            "Rank": "BI top 103",
            "Company": "Eagle Pharmaceuticals",
            "Website": "www.eagleus.com",
            "Address": "50 Tice Blvd\r\nWoodcliff Lake\r\nNJ 07677 USA",
            "Country": "United States",
            "Phone": "201.326.5300"
        },
        {
            "Rank": "BI top 103",
            "Company": "Osmotica Pharmaceuticals",
            "Website": "www.osmotica.com",
            "Address": "400 Crossing Blvd\r\nBridgewater NJ 08807",
            "Country": "United States",
            "Phone": "908.809.1300"
        },
        {
            "Rank": "BI top 103",
            "Company": "Momenta Pharmaceuticals",
            "Website": "www.momentapharma.com",
            "Address": "301 Binney St\r\nCambridge MA 02142",
            "Country": "United States",
            "Phone": "617.491.9700"
        },
        {
            "Rank": "BI top 103",
            "Company": "Amphastar Pharmaceuticals",
            "Website": "www.amphastar.com",
            "Address": "11570 Sixth St\r\nRancho Cucamonga\r\nCA 91730 USA",
            "Country": "United States",
            "Phone": "800.423.4136"
        },
        {
            "Rank": "BI top 103",
            "Company": "Navamedic ASA",
            "Website": "www.navamedic.com",
            "Address": "Fornebuveien 42\r\nLysaker 1325 Norway",
            "Country": "Norway",
            "Phone": "+47 67 11 25 40"
        },
        {
            "Rank": "BI top 103",
            "Company": "ProPhase Labs",
            "Website": "www.prophaselabs.com",
            "Address": "Po Box 1349\r\nDoylestown PA 18901 USA",
            "Country": "United States",
            "Phone": "800.505.2653"
        }
    ];

/*
var $table = $('#table')
var $button = $('#button')

$(function() {
  $button.click(function () {
    alert('getSelections: ' + JSON.stringify($table.bootstrapTable('getSelections')))
  })
});
*/

function WebsiteLinkFormatter(value, row) {
  return "<a href='" + 'https://' + value + "'>" + value + "</a>";
}
function CompanyLinkFormatter(value, row) {
  return "<a href='" + value + "'>" + value + "</a>";
}


/*
window.operateEvents = {
  'click .like': function (e, value, row) {
    alert('You click like action, row: ' + JSON.stringify(row))
  },
  'click .remove': function (e, value, row) {
    alert('You click remove action, row: ' + JSON.stringify(row))
  }
}

function operateFormatter(value, row, index) {
  return [
    '<a class="like" href="javascript:void(0)" title="Report">',
    '<i class="fa fa-heart"></i>',
    '</a>  '
  ].join('')
}
*/

function operateFormatter(value, row, index) {
    return [
        '<a class="like btn" data-unique-id="',row.id,'" data-toggle="viewReportModal" data-target="#viewReportModal',row.id,'">',
        '<i class="fa fa-heart"></i>',
        '</a>'
    ].join('');
}

window.operateEvents = {
  'click .like': function (e, value, row) {
  // the row param is what you want to display, for example: row.id
  $('#viewReportModal').modal('show')
      .find('.modal-body').html('<pre>' +
      JSON.stringify(row, null, 4) + '</pre>')
}
};


function countryFormatter(value, row) {
  if (value === "United States") {
    return '<span class="flag-icon flag-icon-us"></span>' + value
  }
  else if (value === "Hungary") {
    return '<span class="flag-icon flag-icon-hu"></span>' + value
  }
  else if (value === "Ireland") {
    return '<span class="flag-icon flag-icon-ie"></span>' + value
  }
  else if (value === "France") {
    return '<span class="flag-icon flag-icon-fr"></span>' + value
  }
  else if (value === "Germany") {
    return '<span class="flag-icon flag-icon-de"></span>' + value
  }
  else if (value === "India") {
    return '<span class="flag-icon flag-icon-in"></span>' + value
  }
  else if (value === "Italy") {
    return '<span class="flag-icon flag-icon-it"></span>' + value
  }
  else if (value === "Poland") {
    return '<span class="flag-icon flag-icon-pl"></span>' + value
  }
  else if (value === "Spain") {
    return '<span class="flag-icon flag-icon-es"></span>' + value
  }
  else if (value === "Puerto Rico") {
    return '<span class="flag-icon flag-icon-pr"></span>' + value
  }
  else if (value === "Brazil") {
    return '<span class="flag-icon flag-icon-br"></span>' + value
  }
  else if (value === "Canada") {
    return '<span class="flag-icon flag-icon-ca"></span>' + value
  }
  else if (value === "Australia") {
    return '<span class="flag-icon flag-icon-au"></span>' + value
  }
  else if (value === "Argentina") {
    return '<span class="flag-icon flag-icon-ar"></span>' + value
  }
  else if (value === "Austria") {
    return '<span class="flag-icon flag-icon-at"></span>' + value
  }
  else if (value === "Bulgaria") {
    return '<span class="flag-icon flag-icon-bg"></span>' + value
  }
  else if (value === "China") {
    return '<span class="flag-icon flag-icon-cn"></span>' + value
  }
  else if (value === "Belgium") {
    return '<span class="flag-icon flag-icon-be"></span>' + value
  }
  else if (value === "Finland") {
    return '<span class="flag-icon flag-icon-fi"></span>' + value
  }
  else if (value === "Czech Republic") {
    return '<span class="flag-icon flag-icon-cz"></span>' + value
  }
  else if (value === "Croatia") {
    return '<span class="flag-icon flag-icon-hr"></span>' + value
  }
  else if (value === "Colombia") {
    return '<span class="flag-icon flag-icon-co"></span>' + value
  }
  else if (value === "United Kingdom") {
    return '<span class="flag-icon flag-icon-gb"></span>' + value
  }
  else if (value === "Serbia") {
    return '<span class="flag-icon flag-icon-rs"></span>' + value
  }
  else if (value === "Netherlands") {
    return '<span class="flag-icon flag-icon-nl"></span>' + value
  }
  else if (value === "Switzerland") {
    return '<span class="flag-icon flag-icon-ch"></span>' + value
  }
  else if (value === "Japan") {
    return '<span class="flag-icon flag-icon-jp"></span>' + value
  }
  else if (value === "Romania") {
    return '<span class="flag-icon flag-icon-ro"></span>' + value
  }
  else if (value === "Russia") {
    return '<span class="flag-icon flag-icon-ru"></span>' + value
  }
  else if (value === "Israel") {
    return '<span class="flag-icon flag-icon-il"></span>' + value
  }
  else if (value === "Mexico") {
    return '<span class="flag-icon flag-icon-mx"></span>' + value
  }
  else if (value === "Norway") {
    return '<span class="flag-icon flag-icon-no"></span>' + value
  }
  else if (value === "Philippines") {
    return '<span class="flag-icon flag-icon-ph"></span>' + value
  }
  else if (value === "Portugal") {
    return '<span class="flag-icon flag-icon-pt"></span>' + value
  }
  else if (value === "Slovenia") {
    return '<span class="flag-icon flag-icon-sl"></span>' + value
  }
  else if (value === "South Africa") {
    return '<span class="flag-icon flag-icon-za"></span>' + value
  }
  else if (value === "South Korea") {
    return '<span class="flag-icon flag-icon-kr"></span>' + value
  }
  else if (value === "Sweden") {
    return '<span class="flag-icon flag-icon-se"></span>' + value
  }
  else if (value === "Turkey") {
    return '<span class="flag-icon flag-icon-tr"></span>' + value
  }
  else if (value === "Uruguay") {
    return '<span class="flag-icon flag-icon-uy"></span>' + value
  }
  else if (value === "Indonesia") {
    return '<span class="flag-icon flag-icon-id"></span>' + value
  }
  return '<i class="fa fa-globe"></i>' + value
}


function detailFormatter(index, row) {
var html = []
$.each(row, function (key, value) {
  html.push('<tr><td><b>' + key + ':</b></td> <td>' + value + '</td>' + '<tr>')
})
return html.join('')
};

$(function () {
  $table = $('#table');
  $table.bootstrapTable({
      undefinedText: 'N/A',
      data: data
  });
});
